<SEC-DOCUMENT>0001628280-23-028201.txt : 20230808
<SEC-HEADER>0001628280-23-028201.hdr.sgml : 20230808
<ACCEPTANCE-DATETIME>20230808161538
ACCESSION NUMBER:		0001628280-23-028201
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230808
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230808
DATE AS OF CHANGE:		20230808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOLIFE SOLUTIONS INC
		CENTRAL INDEX KEY:			0000834365
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				943076866
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36362
		FILM NUMBER:		231151530

	BUSINESS ADDRESS:	
		STREET 1:		3303 MONTE VILLA PARKWAY
		STREET 2:		SUITE 310
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		4254011400

	MAIL ADDRESS:	
		STREET 1:		3303 MONTE VILLA PARKWAY
		STREET 2:		SUITE 310
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOLIFE SOLUTION INC
		DATE OF NAME CHANGE:	20030113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CRYOMEDICAL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>blfs-20230808.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:849b9e6c-3ba3-4baf-970d-c9c557b83ff8,g:4070b7d4-6e90-43c3-a241-858a6dea9257,d:8fcc35fbe18a437586e3ef327c34879c--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>blfs-20230808</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-21">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0000834365</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="blfs-20230808.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000834365</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-08</xbrli:startDate><xbrli:endDate>2023-08-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8fcc35fbe18a437586e3ef327c34879c_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 8, 2023</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">BIOLIFE SOLUTIONS, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-36362</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">94-3076866</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>&#160;incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3303 Monte Villa Parkway</ix:nonNumeric>,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Bothell</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">WA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">98021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">425</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">402-1400</ix:nonNumeric></span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">N/A</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Former name or former address, if changed since last report)</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.750%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trading symbol</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Name of exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">BioLife Solutions, Inc. Common Stock</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">BLFS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" id="f-19">NASDAQ</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8fcc35fbe18a437586e3ef327c34879c_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2023, BioLife Solutions, Inc., a Delaware corporation, issued a press release announcing unaudited financial results and operational highlights for the second quarter ended June 30, 2023. A copy of the press release is furnished as Exhibit 99.1 to this current report on Form 8-K.</span></div><div id="i8fcc35fbe18a437586e3ef327c34879c_10"></div><div style="-sec-extract:summary;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="blfsq22023earningsrelease.htm">Press release, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="blfsq22023earningsrelease.htm">August 8</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="blfsq22023earningsrelease.htm">, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8fcc35fbe18a437586e3ef327c34879c_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BioLife Solutions, Inc.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August 8, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Troy Wichterman</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Troy Wichterman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: Chief Financial Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>blfsq22023earningsrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i609077d418c54131b4bb7529e798a899_1"></div><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#191611;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Committed to Divesting Stirling Ultracold and Custom Biogenic Systems by End of 2023</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Conference call begins at 4&#58;30 p.m. Eastern time today</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">BOTHELL, Wash. (August&#160;8, 2023) &#8211; </font><font style="color:#0066cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">BioLife Solutions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">, Inc. (Nasdaq&#58; BLFS)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> (&#8220;BioLife&#8221; or the &#8220;Company&#8221;), </font><font style="color:#191611;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today </font><font style="background-color:#ffffff;color:#373737;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">announced financial results for the second quarter and six months of 2023</font><font style="color:#191611;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> and updated guidance for the full year 2023. Management is also providing a first half 2023 financial profile of certain pro forma financial metrics excluding Stirling Ultracold (Stirling) and Custom Biogenic Systems (CBS) freezer assets, both of which management intends to divest by December 31, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#191611;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Mike Rice, Chairman and CEO, commented, &#8220;Subsequent to the end of the second quarter 2023, after considering other strategic alternatives, management and the board of directors have determined that divesting our Stirling and CBS freezer assets would optimize the performance of our product portfolio by focusing on recurring higher margin streams and create the most shareholder value.</font><font style="color:#191611;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#191611;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We made significant progress to achieve this objective and based on the level of interest and the feedback we have received so far&#59; we are fully committed to starting 2024 without the impact of the freezer product lines.</font><font style="color:#191611;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#191611;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We continue to appreciate the value of the related IP, products and teams, and believe a buyer or buyers will materialize that can continue to provide global access to these innovative products in a cost structure that fits their financial requirements.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#1d1b11;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Management anticipates reclassifying the freezer product lines as Assets Held for Sale and Discontinued Operations in the second half of 2023 when the accounting criteria are met.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#1d1b11;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">To assist investors with understanding the positive impacts of these potential divestitures, the Company is now providing certain unaudited pro forma financial information had the divestitures occurred on January 1, 2023. This unaudited pro forma financial information is presented for informational purposes only and is not intended to represent or be indicative of the results had the divestiture occurred at an earlier date and should not be taken as representative of our future consolidated results of operations or financial condition.</font><font style="color:#1d1b11;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#1d1b11;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Preparation of this certain unaudited pro forma financial information required management to make certain judgments and estimates to determine the adjustments based on information currently available, which is subject to management&#8217;s ongoing process as part of the divestiture transaction. Actual results may differ from the assumptions used to present this certain unaudited pro forma financial information.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#1d1b11;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The following table illustrates BioLife&#8217;s financial results for the first half of 2023 excluding revenues and costs associated with our freezer assets.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:52.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported Results</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro Forma Results Excluding Freezers</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Q2 2023 YTD</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Q2 2023 YTD</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,210&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,548&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Margin</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Gross Margin</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,247)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$              8,216 - 9,216</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA %</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 - 18 %</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1) Adjusted EBITDA (non-GAAP) for the pro forma results excluding freezers was calculated utilizing certain estimates and judgments by management utilizing the most updated information available at this time. Given that estimated results may vary, a range of Adjusted EBITDA as a percentage of revenue was provided. Due to the level of estimation required, actual results may differ from assumptions used to present this pro forma information.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Mike Rice, Chairman and CEO, further commented, &#8220;We are confident the portfolio of high value recurring products and services, and expected strong resulting financial profile, after the divestiture of the freezer businesses, will better align BioLife to the attractive growth and profitability opportunities for a key supplier to the CGT industry. We sell critical CGT products that are sole-sourced from BioLife. These are not one-time buys but rather consumables that need to be replenished. We have a strong brand and track record with limited competitive substitutes. Our CGT customers participate in an emerging class of therapeutic modalities that are just now becoming real, and we naturally expect demand for our products to increase as they progress their programs.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The reality is just that right now, the economy is tighter, and the participants in this ecosystem all want to reduce cash burn.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Sustained catalysts that we expect to drive BioLife growth due to a significant increase in the number of manufactured doses include&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Approvals of new cell and gene therapies</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Additional approvals of commercial CGT in new geographies</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Additional approvals of CGT in new indications</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Migration of commercial therapies to first or second-line treatment</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">An eventual transition to allogeneic therapies</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In the near term, results continue to be impacted by constraints pressuring the broader bioprocessing sector including the following factors&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Macro headwinds of global economic uncertainty causing reduced biotech spending across our customer base not only for capital equipment but also consumables. We believe these are more transitory, and similar to the outlooks of our bioprocessing peers, anticipate a recovery in 2024 as customer supply chain dynamics improve.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Cell processing revenue concentration and lumpiness caused by&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.11pt">Destocking by our largest direct customer compared to prior year period. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.11pt">Slowed growth from our largest distributor compared to prior period, caused by</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">several of their downstream clinical customers having to complete validation of a new media product final container we introduced to mitigate supply chain shortages.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Several clinical CGT customers&#8217; reduced spending due to reduced clinical trial activity (trial early termination, pauses between phases and delayed patient enrollment).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Manufacturing bottlenecks at some CGT customers or their related CMOs due to capacity constraints and&#47;or shortages of raw materials from other suppliers.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Troy Wichterman, Chief Financial Officer, commented, &#8220;While near term results are disappointing, we remain confident in the mid- and long-term growth potential for BioLife and our ability to generate cash flows from operations post our freezer divestitures.&#34;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Second Quarter 2023 Customer Highlights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">New Customer Acquisition</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.652%"><tr><td style="width:1.0%"></td><td style="width:34.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Platform&#47;Solution</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Q1 2023</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Q2 2023</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1H2023</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY2022</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Biopreservation Media</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sexton Cell Processing</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SciSafe&#174; Storage Services</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">99</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thaw</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">evo&#174; Cold Chain</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">34</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cryogenic Freezers</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">82</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ULT Freezers</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">121</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">102</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">223</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">461</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TOTAL</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">197</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">188</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">385</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">822</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Gained nearly 200 new customers.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Processed 20 new USA Master File cross references for our cell processing solutions. We estimate that over 800 total global clinical applications have our BioLife Solutions or Sexton cell processing solutions embedded in their manufacturing processes.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">evo cold chain management shipments of cell and gene therapies totaled 3,019 in Q2 2023</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div id="i609077d418c54131b4bb7529e798a899_40"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Second Quarter 2023 Financial Results</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BioLife Solutions is presenting various financial metrics under U.S. Generally Accepted Accounting Principles (GAAP) and as adjusted (non-GAAP). A reconciliation of GAAP to non-GAAP metrics appears at the end of this news release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REVENUE</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Total revenue for the second quarter of 2023 was $39.5 million, a decrease of $1.0 million, or 3%, from $40.5 million for the second quarter of 2022. There was no COVID-19 related revenue in the second quarter of 2023. Ex-COVID related revenue growth for the second quarter of 2023 was 7%.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.11pt">Cell Processing platform revenue was $18.7 million, up $3.3 million, or 22%, over the same period in 2022. Biopreservation media growth was 21%.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.11pt">Freezers and Thaw Systems platform revenue was $13.9 million, down $4.8 million, or 26%, over the same period in 2022. Ex-COVID related revenue was down $4.1 million, or 23%, over the same period in 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.11pt">Storage and Storage Services platform revenue was $6.9 million, up $0.4 million, or 7%, over the same period in 2022. Ex-COVID related revenue growth was $3.4 million, or 94%, over the same period in 2022. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Total revenue for the six months ended June&#160;30, 2023 was $77.2 million, an increase of 1% from $76.8 million for 2022. There was no COVID-19 related revenue in the six months ended June&#160;30, 2023. Ex-COVID related revenue growth for the second quarter of 2023 was 11%.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.11pt">Cell Processing platform revenue was $37.7 million, up $7.4 million, or 24%, over the same period in 2022. Biopreservation media growth was 24%.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.11pt">Freezers and Thaw Systems platform revenue was $26.9 million, down $7.1 million, or 21%, over the same period in 2022. Ex-COVID related revenue was down $5.9 million, or 18%, over the same period in 2022. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.11pt">Storage and Storage Services platform revenue was $12.6 million, up $0.1 million, or 1%, over the same period in 2022. Ex-COVID related revenue growth was $6.2 million, or 96%, over the same period in 2022. </font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GROSS MARGIN</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.5pt">Gross margin (GAAP) for the second quarter of 2023 was 28% compared with 33% for the second quarter of 2022. Adjusted gross margin (non-GAAP) for the second quarter of 2023 was 35% compared with 36% for the second quarter of 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.5pt">Gross margin (GAAP) for the six months ended June&#160;30, 2023 was 32% compared with 31% for the six months ended 2022. Adjusted gross margin (non-GAAP) for the six months ended June&#160;30, 2023 was 36% compared with 34% for the first six months ended of 2022. </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">The decrease in gross margin for the second quarter of 2023 was primarily due to increases in personnel expenses and an inventory reserve related to potentially unusable final product containers from a key supplier. The increase in gross margin for the six months ended June 30, 2023 was primarily due to a favorable product mix in our biopreservation media product line and a greater concentration of higher margin revenue as a percentage of total revenue in comparison to the same period in 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OPERATING EXPENSE</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Operating expense (GAAP) for the second quarter of 2023 was $54.8 million compared with $117.1 million for the second quarter of 2022. Adjusted operating expense (non-GAAP) for the second quarter of 2023 was $22.2 million compared with $20.3 million for the second quarter 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Operating expense (GAAP) for the six months ended June&#160;30, 2023 was $106.1 million compared with $161.3 million for the six months ended 2022. Adjusted operating expense (non-GAAP) for the six months ended June&#160;30, 2023 was $46.8 million compared with $40.4 million for 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">The decrease in GAAP operating expenses is primarily due to the $69.9 million intangible asset impairment charge that occurred in Q2 2022. The increase in non-GAAP operating expenses for the three and six months ended of June&#160;30, 2023 was primarily due to increases in professional services fees and employee compensation costs from an increase in headcount compared to the prior year.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OPERATING LOSS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Operating loss (GAAP) for the second quarter of 2023 was $15.3 million compared with $76.6 million for the second quarter of 2022. Adjusted operating loss (non-GAAP) for the second quarter of 2023 was $10.4 million compared with $5.7 million for the second quarter of 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Operating loss (GAAP) for the six months ended June&#160;30, 2023 was $28.9 million compared with $84.5 million for the six months ended 2022. Adjusted operating loss (non-GAAP) for the six months ended June&#160;30, 2023 was $21.0 million compared with $14.1 million for the first six months ended of 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NET LOSS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Net loss (GAAP) for the second quarter of 2023 was $10.2 million compared with $72.9 million for the second quarter of 2022. Adjusted net loss (non-GAAP) for the second quarter of 2023 was $10.4 million compared with $5.8 million for the second quarter of 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Net loss (GAAP) for the six months ended June&#160;30, 2023 was $23.9 million compared with $80.3 million for the six months ended 2022. Adjusted net loss (non-GAAP) for the six months ended June&#160;30, 2023 was $21.0 million compared with $14.2 million for the first six months ended of 2022. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LOSS PER SHARE</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Loss per share (GAAP) for the second quarter of 2023 was $0.23 compared with loss per share of $1.72 for the second quarter of 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Loss per share (GAAP) for the six months ended June&#160;30, 2023 was $0.55 compared with loss per share of $1.90 for the first six months ended of 2022.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ADJUSTED EBITDA</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Adjusted EBITDA, a non-GAAP measure, for the second quarter of 2023 was negative $1.2 million compared with $1.2 million for the second quarter of 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Adjusted EBITDA, a non-GAAP measure, for the six months ended June&#160;30, 2023 was negative $2.2 million compared with $44,000 for the first six months ended of 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Cash, cash equivalents, and marketable securities as of June&#160;30, 2023, were $48.1 million.</font></div><div><font><br></font></div><div><font><br></font></div><div id="i609077d418c54131b4bb7529e798a899_53"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">2023 Revenue Guidance</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">BioLife Solutions is updating 2023 revenue guidance, which is based on expectations for its existing business.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total revenue for 2023 is expected to range from $144 million to $158 million, reflecting a year-over-year decrease of 11% to 2%. Excluding COVID-19-related revenue, this range reflects a year-over-year decrease of 3% to an increase of 6%. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expectations for 2023 total revenue include the following platform contributions&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.5pt">Cell processing platform&#58; $65.0 million to $74.0 million, a decrease of 5% to an increase of 8% over 2022. Previous guidance estimated revenues to be $89.0 - $93.0 million.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.5pt">Freezers and Thaw Systems platform&#58; $53.0 million to $56.0 million, an decrease of 21% to 16% compared to 2022. Excluding COVID-19-related revenue, year-over-year decrease of 18% to 13%. Previous guidance estimated revenues to be $72.5 - $79.0 million.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.5pt">Storage and Storage Services platform&#58; $26.0 million to $28.0 million, a decrease of 2% to an increase of 6% over 2022. Excluding COVID-19-related revenue, year-over-year growth of 61% to 74%. Previous guidance estimated revenues to be $26.5 - $30.0 million.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:justify"><font><br></font></div><div id="i609077d418c54131b4bb7529e798a899_66"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Conference Call &#38; Webcast</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Management will discuss the Company's financial results, provide a general business update and answer questions during a conference call and live webcast today at 4&#58;30 p.m. ET (1&#58;30 p.m. PT).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at&#160;</font><font style="background-color:#ffffff;color:#0066cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.biolifesolutions.com&#47;earnings.</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> In addition, the conference call will be accessible by dialing toll-free (800) 715-9871 for domestic callers or (646) 307-1963 for international callers. The conference ID number is 4014878. A webcast replay will be available approximately two hours after the call ends and will be archived on&#160;</font><font style="background-color:#ffffff;color:#0066cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.biolifesolutions.com&#47;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;for 90 days.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">About BioLife Solutions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary&#160;</font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CryoStor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;and </font><font style="color:#0070c0;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">HypoThermosol</font><font style="color:#0070c0;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">biopreservation media for shipping and storage, the </font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ThawSTAR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;family of automated, water-free thawing products,&#160;</font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">evo</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;cold chain management system,&#160;&#160;</font><font style="color:#0066cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">high capacity cryogenic storage freezers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Stirling Ultracold</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;mechanical freezers,&#160;</font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SciSafe</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;biologic storage services, and </font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sexton Biotechnologies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> cell processing tools.  For more information, please visit </font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">www.biolifesolutions.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">www.scisafe.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">www.stirlingultracold.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or </font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">www.sextonbio.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;and follow BioLife on </font><font style="color:#4472c4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Cautions Regarding Forward Looking Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Certain statements contained in this press release are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;designed,&#8221; and similar words are intended to identify forward-looking statements. Forward-looking statements are based on our current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of certain of these risks, uncertainties and other matters can be found in filings we make with the U.S. Securities and Exchange Commission, all of which are available at www.sec.gov. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by us. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  We undertake no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP Measures of Financial Performance&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">To supplement our financial statements, which are presented on the basis of U.S. generally accepted accounting principles (GAAP), the following non-GAAP measures of financial performance are included in this release&#58; adjusted gross profit and gross margin, adjusted operating expenses, adjusted operating income&#47;(loss), adjusted net income&#47;(loss), earnings before interest, taxes, depreciation and amortization (EBITDA), and adjusted EBITDA. A reconciliation of GAAP to adjusted non-GAAP financial measures is included as an attachment to this press release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">We believe these non-GAAP financial measures are useful to investors in assessing our operating performance. We use these financial measures internally to evaluate our operating performance and for planning and forecasting of future periods.  We also believe it is in the best interests of investors to provide this non-GAAP information.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">While we believe these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with our consolidated financial statements prepared in accordance with GAAP.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.306%"><tr><td style="width:1.0%"></td><td style="width:92.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.117%"></td><td style="width:0.1%"></td></tr><tr style="height:1pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Media &#38; Investor Relations</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">At the Company</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Troy Wichterman </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(425) 402-1400</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#0066cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">twichterman&#64;biolifesolutions.com</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Investors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LHA Investor Relations</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jody Cain</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(310) 691-7100</font></div><div><font style="color:#0066cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">jcain&#64;lhai.com</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:center"><font><br></font></div><div id="i609077d418c54131b4bb7529e798a899_79"></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands, except share and per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:39.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(In thousands, except per share and share data)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Product revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">33,037&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">34,170&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">64,630&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">64,558&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Service revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">4,195&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">3,698&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">8,665&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">6,787&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Rental revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">2,276&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">2,665&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">3,915&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,407&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total product, rental, and service revenue</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">39,508&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">40,533&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">77,210&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">76,752&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Costs and operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of product, rental, and service revenue (exclusive of Intangible asset amortization)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">27,696&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">26,194&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">51,359&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">50,640&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">15,402&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">11,652&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">30,241&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">23,182&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Sales and marketing</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">6,318&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,415&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">12,789&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">10,306&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">4,840&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">3,428&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">8,995&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">7,209&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Intangible asset impairment charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">69,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">69,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Intangible asset amortization</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,450&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">2,863&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">2,911&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,725&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Acquisition costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">16&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Change in fair value of contingent consideration</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(918)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(2,361)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(198)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(5,695)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">54,788&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">117,096&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">106,097&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">161,283&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Operating loss</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(15,280)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(76,563)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(28,887)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(84,531)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other income (expense)&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Gain on settlement of Global Cooling escrow</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,115&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,115&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Interest expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(419)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(32)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(829)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(216)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other income (expense)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">390&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(22)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">785&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">110&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total other income (expense), net</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,086&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(54)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,071&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(106)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Loss before income tax (expense) benefit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(10,194)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(76,617)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(23,816)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(84,637)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Income tax (expense) benefit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">3,739&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(97)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">4,338&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(10,199)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(72,878)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(23,913)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(80,299)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss attributable to common shareholders&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Basic and Diluted</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(10,199)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(72,878)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(23,913)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(80,299)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss per share attributable to common shareholders&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Basic and Diluted</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(0.23)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(1.72)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(0.55)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(1.90)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Weighted average shares used to compute loss per share attributable to common shareholders&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Basic and Diluted</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">43,441,219</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">42,460,189</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">43,235,558</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">42,238,355</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:41.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,199)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(72,878)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(23,913)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(80,299)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other comprehensive income (loss)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(462)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">180&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(618)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Comprehensive loss</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,164)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(73,340)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(23,733)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(80,917)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED BALANCE SHEET INFORMATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:69.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.369%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and marketable securities</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,128&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,065&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,724&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,870&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,311&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,452&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,587&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,582&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,177&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,229&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term obligations</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,462&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,459&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270,828)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246,915)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders' equity</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,128&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364,188&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS INFORMATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:69.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.369%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in operating activities</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,430)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,841)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in (provided by) investing activities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,218&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,340)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in (provided by) financing activities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of currency translation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net decrease (increase) in cash, cash equivalents, and restricted stock</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,841)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP GROSS PROFIT TO NON-GAAP ADJUSTED GROSS PROFIT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:41.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP GROSS PROFIT</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,079&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,246&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,385&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,926&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP GROSS MARGIN</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTMENTS TO GROSS PROFIT&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory step-up</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTED GROSS PROFIT</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,997&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,590&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,036&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,363&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTED GROSS MARGIN</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP OPERATING EXPENSES TO NON-GAAP ADJUSTED OPERATING EXPENSES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:41.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP OPERATING EXPENSES</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,788&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,096&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,097&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,283&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTMENTS TO OPERATING EXPENSES&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product, rental, and service revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,696)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,194)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,359)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,640)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,185)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,185)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,143)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,976)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,863)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,911)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,725)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,695&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,900)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,900)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTED OPERATING EXPENSES</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,213&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,333&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,836&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,440&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP OPERATING LOSS TO NON-GAAP ADJUSTED OPERATING LOSS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:41.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">GAAP OPERATING LOSS</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,280)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,563)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,887)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,531)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ADJUSTMENTS TO GAAP OPERATING LOSS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory step-up</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,143&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,725&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(918)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,361)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,695)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ADJUSTED OPERATING LOSS</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,401)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,743)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,985)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,077)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP NET LOSS TO NON-GAAP ADJUSTED NET LOSS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:41.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">GAAP NET LOSS</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,199)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,878)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,913)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,299)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ADJUSTMENTS TO GAAP NET LOSS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory step-up</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,143&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,725&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(918)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,361)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,695)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax expense &#47; (benefit)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,739)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,338)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gain on settlement of Global Cooling escrow</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,115)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,115)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ADJUSTED NET LOSS</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,430)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,797)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,029)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,183)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP NET LOSS TO NON-GAAP ADJUSTED EBITDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:41.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP NET LOSS</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,199)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,878)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,913)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,299)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTMENTS&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense &#47; (benefit)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,739)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,338)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,733&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,639&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,725&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,322)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,736)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,343)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,057)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER ADJUSTMENTS&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation (non-cash)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,856&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,973&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,372&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory step-up</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,143&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(918)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,361)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,695)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on settlement of Global Cooling escrow</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,115)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,115)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTED EBITDA</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,152)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,247)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                      </font><img alt="imagea.jpg" src="imagea.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                       </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3303 Monte Villa Parkway, Suite 310  &#124;  Bothell, WA 98021 USA  &#124;  866.424.6543 phone  &#124;  BioLifeSolutions.com</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BIOLIFE SOLUTIONS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP NET LOSS TO NON-GAAP ADJUSTED EBITDA EXCLUDING FREEZER BUSINESS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited, amounts in thousands)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.291%"><tr><td style="width:1.0%"></td><td style="width:47.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.539%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Six Months Ended<br>June 30, 2023</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Freezers</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Excluding Freezers</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Results</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP NET LOSS</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,090)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,823)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,913)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense allocation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,174)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,174&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP NET LOSS AS ADJUSTED FOR EXPENSE ALLOCATION</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,264)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,649)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,913)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTMENTS&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense &#47; (benefit)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,178&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,733&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,408&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,095)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,248)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,343)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER ADJUSTMENTS&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation (non-cash)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,632&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,588&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on settlement of Global Cooling escrow</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,115)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,115)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADJUSTED EBITDA</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,463)</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,216&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,247)</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1) Expense allocations reflected here represent allocations made by the corporate entity for the benefit of the freezer business (Stirling Ultracold and Custom Biogenic Systems). These allocations were calculated using certain judgments and estimates based on information currently available, though actual results may differ from assumptions used to present this pro forma information.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">#   #   #</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 15</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>blfs-20230808.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:849b9e6c-3ba3-4baf-970d-c9c557b83ff8,g:4070b7d4-6e90-43c3-a241-858a6dea9257-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:blfs="http://www.biolifesolutions.com/20230808" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.biolifesolutions.com/20230808">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="blfs-20230808_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="blfs-20230808_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.biolifesolutions.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>blfs-20230808_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:849b9e6c-3ba3-4baf-970d-c9c557b83ff8,g:4070b7d4-6e90-43c3-a241-858a6dea9257-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_0b5630d9-88db-42e0-ab6f-81d29fc67b80_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cef3967e-4ea0-4dba-9b50-34abc18e11a4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_56024323-dcdf-454a-bc50-d30c197803d4_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_84f5fc1c-8e85-45e8-8a22-b1bffe355024_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2ab381d2-e311-4ff5-8005-9c7ba4a3f8e0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a016c6f3-cc6a-4b17-8334-d904bf275014_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fffe6d48-522b-413a-b0ca-fb7c96f80800_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_4cd2d3e2-edaa-4749-b6f3-8fc3ccd68d49_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6524547a-967c-4e85-b9b8-40754a6d505b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_65fde1e1-118f-474b-ae84-16dbd91e54bf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_86a8e4d3-ce48-4e3a-ad80-2773fa73ffe8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_daea50f3-d14e-4055-a9cf-28dd69fce3c9_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_15c26eae-9e0a-464d-923f-7db8f7815198_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a5aaf179-697c-4caa-8ffd-4f9c8ed25b89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f63c7025-220a-49fb-8300-edd8730cd749_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_82e90b45-04a6-4dde-b2a5-368248633970_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b603ed6e-9291-471e-9ff0-3a7ed45652a1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_71a6cbcb-2028-4f4e-bb0c-2f6a685767b7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a0a78630-8f33-4eaf-96fa-9959ab4abcab_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_61ae0289-7f64-443f-b02b-9d0c9dc1abf6_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bb2f4206-1418-4e54-863b-9dc30e010fd0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d15a7baa-0816-492d-96a7-ed31c4a6e29a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>blfs-20230808_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:849b9e6c-3ba3-4baf-970d-c9c557b83ff8,g:4070b7d4-6e90-43c3-a241-858a6dea9257-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.biolifesolutions.com/role/Cover" xlink:type="simple" xlink:href="blfs-20230808.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.biolifesolutions.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f7b3ceba-026a-4785-8ad6-ec81b7fe4abb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_DocumentType_f7b3ceba-026a-4785-8ad6-ec81b7fe4abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8817e908-663c-4654-909d-aac8c09b90de" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_DocumentPeriodEndDate_8817e908-663c-4654-909d-aac8c09b90de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_76350b81-069a-4e9b-adbf-f541acf1f603" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityRegistrantName_76350b81-069a-4e9b-adbf-f541acf1f603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c084ceda-d10b-4eda-80a4-5c8cb4fdc918" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c084ceda-d10b-4eda-80a4-5c8cb4fdc918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9722b187-b276-443d-9fd2-0d1da31c4f2f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityFileNumber_9722b187-b276-443d-9fd2-0d1da31c4f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_05e4541b-afa7-4dd8-8c0c-98feeec5325c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityTaxIdentificationNumber_05e4541b-afa7-4dd8-8c0c-98feeec5325c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a922b7dc-d338-48ec-9d58-79babd881efb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityAddressAddressLine1_a922b7dc-d338-48ec-9d58-79babd881efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_606a98c5-739a-43c5-bdf1-28364d018acf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityAddressCityOrTown_606a98c5-739a-43c5-bdf1-28364d018acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2c965f1c-325b-4cea-a4c7-8f85c03e0a1a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityAddressStateOrProvince_2c965f1c-325b-4cea-a4c7-8f85c03e0a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1d758205-5a83-4f3b-827b-77d7a97dd2c4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityAddressPostalZipCode_1d758205-5a83-4f3b-827b-77d7a97dd2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ea8a307f-b9d7-4634-a6fd-ccde9179311f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_CityAreaCode_ea8a307f-b9d7-4634-a6fd-ccde9179311f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_249f88b3-4d47-48e5-9b1e-8ce2075eb86e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_LocalPhoneNumber_249f88b3-4d47-48e5-9b1e-8ce2075eb86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_344aebeb-87f3-4898-8409-38c4cf103b15" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_WrittenCommunications_344aebeb-87f3-4898-8409-38c4cf103b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_4d2805b2-1267-403f-b4ef-39c336546cfc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_SolicitingMaterial_4d2805b2-1267-403f-b4ef-39c336546cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_97384b0d-cadb-45c8-ae12-83ef704667d6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_PreCommencementTenderOffer_97384b0d-cadb-45c8-ae12-83ef704667d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_fab947c3-c19f-4186-8731-ec8aa5a59417" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_fab947c3-c19f-4186-8731-ec8aa5a59417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_01fc8dfb-b74d-4d8d-935d-3e3e1ba402fd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_Security12bTitle_01fc8dfb-b74d-4d8d-935d-3e3e1ba402fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_82b12466-fd61-4947-98c5-a94aa04be3af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_TradingSymbol_82b12466-fd61-4947-98c5-a94aa04be3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_23a411f9-57f9-4e2d-b7d8-6e4acd323e13" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_SecurityExchangeName_23a411f9-57f9-4e2d-b7d8-6e4acd323e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8a39b119-9c9d-4758-8207-493644727f33" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityEmergingGrowthCompany_8a39b119-9c9d-4758-8207-493644727f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_aacfba10-1294-46de-9320-532b924070f3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_AmendmentFlag_aacfba10-1294-46de-9320-532b924070f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_36406e66-0f80-4dee-89a4-a970e199fc0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9225e28-d162-430a-a0c0-77eebfc4a8a4" xlink:to="loc_dei_EntityCentralIndexKey_36406e66-0f80-4dee-89a4-a970e199fc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>imagea.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 imagea.jpg
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M*P62PQV&8X5DHU#]2]TFYC?B\I,L18 X5Y;5<2W54BW54BW54BW54BU][TA
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M[XL?L2V;W6L;-GK(-FKZO&W2O(]MU&RP;=!XA-5K/-;J-WO%ZK=\U>JT>EE
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M!; %>IN.MCHMQ@DT"URS;1^^V2U9!(G/M4!V&X'DM@+0;?#E%MAN">!F)EM
MNJ6 <RLXP#9'_59XG6#]KMMFI-5M.TKG+*P4X"8<P*TP7T3)8LMF>E['#16^
M29L!MI'ROGF+QVROBYZS4_\QPJ[J_KYUGK+()BTIMMG"D8!MY,!B3S9ID0#U
M7P+- FT61THX@.WLK/9JD)T)63<*!0A.5S[G .O1HT?;TT\_[1WCPP\_;$\\
M\83_?NJII[X6)F[XF6>>\8ZX5Z]>-GSX<'OYY9?MK;?>LFG3IMDL@2$,WYJ
M4)2'LJ25.?<W1"<U>/!@>_311SW-YY]_WM-__/''/3_//ONL'_D-/_?<<_;Z
MZZ_[3 =$XT@#@'3:WT8B7VG91)U'.$R](Q/ TB.//)*I\V>>MB>??#(K%^2
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MN$F3)FYP>2T.D6:DRY%&1)K?5L-*OI!5-/9T'CDG[Z^]]II=<\TU7E[JG?I
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MBOAKZ8=+H0-I/0C["H>N5$=5@;:?ZX2(W+<8H!U@6R!(4%"0QXITO4#WHIY
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MDP.U0Y36P?L=X,#OP+WW=;#-S/:^N*?LLIOMIK18*,DLV5@!@'#S@ #:@$"
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M;YT79MA'!>M)7P:TPW4$(Q:&'0,'<PYCY'"M "@MG+_ O^KG7% SIO/F=0G
MC$W=%R]98C-FSK0^??KX"/"G@&T!I5W4R>XK@(W;".XB,$!P;_RS=]C)_7\!
M571"N(#\_;J_V[3WW_=]GJ-\8:0PI/CW+EJPT&<P\"=>MF29+^CB]Y*%BVRI
MCJP8YO>"S^?[_6X )6XZ<X""@XA<@_A-4#J]=>5$!M&Q!%4!VM2SZONKN(Z@
M5]3IP@4+;+'DO%BZL6C>Y[9P[CS_S=L!Y(_.<$3&R!KPZX8JR:M^N(P=N &,
MDP0 VOAGGW[:K[S.>:L"("./,1B$ =ODF5E1=B9AL2.=<6YGF.VP_,<Z\K><
MD"=MFS+G=@34$7Z#/JA-Y <SJ$87V.;OOGOO\YE^)SU*^W&W*3&@FWJ)M@%[
M.TNQZYS2!!BL$C@ND*UUX*W\ +Q9-U%6DAGT$,_++[WLV[@!J!@D ;:Q,^%7
MC__LG;?=[C..:>+9]0':GC?E)>3SOZ2(>[WB39ZI!=H9^E\";<+106RXVW'N
M2:@Z^YBFM+ZD![#Q.QVVSL1C7\;D34P^7=?3UVK"WP15E^ZW@1/9U9CU?UTI
M7?< ;5SSA@X=ZHL?>7O/VT/VT+[BBBO<=_N%%U[PMR7TF1#'/'=;*!(D%%>6
M%SJ !<@"$IF%_4#V<MA'^7;WH&EV]=,OVOV#)MN$SXJ,'5 !V0#LF/EF/H*-
MM.8K7Q-F%=MSHSZR/STZP7[RQSZV;<OG;,.&3UN#LYZU39IVM2W;]+8M6_:P
MC<]ZRC;[]<.V7[OGK-&-(^S&KN]9[W<7V=O+*MU-!+"/)^U"Q;E8[<4!OC)>
M4%JL@0$07RE6LH!-A6(&6X:^DHY"'09'249A.E)H1]MT%CIDGK1YBN*-3PNM
MZZ2Y]M?G)]DOKNIK.[=^PNJ?_:" ]1.6)U!=7_FLW[2SY9WUI&W:Y%D[^++^
MUO3F\7;S\^_:@%<^M=GSU+A7MVN7G^=9#,B>J#QWE)C_\<$J^^U+<^W^R0MM
M6E'&%<<K45FK% BOR%=#8U9[/0G#4!.@C2%C/]T ,@&T,6X8_>.//<[]VOR5
M__^(V.2=CY"P)^]I)YWL0'K';;>WO7;-^/;N#P#4$7<29E_CPRK,L)._2R^Y
MU/>O!&A#I66E_KEP!P3K0S0Z2 <,G ,%XB)8'$8[V\DGX=\Z1I_)=^0SH>J
M=NQ?[MOS*2SJOMH9;>DE^Y6SG2*,+JTOE96F/E0CX@B@ Y!%&'LJQ[9^Z&#H
M)@Q())\ M)CMYJT++D ]NO=PL!=$'9*6NQ^H_K+&]=O&ZTG42RZGB5F4.^^\
MTPX]Y!!?F,S A($J<D1^+#1%9E&?H><,B!QD2W:^W[GDZ&V"Z\D]SH119TJ6
MML'6B0RN7=;*"]>0?4FA!L1)&BR0?/;I9]R-B\$2]4G] K2Q1=3MA=)5=#;*
MPZX169"]CO(BCIH"I)!A\-J(ZP&^PL:N$R7QUP+M#/VO@3;AZ%^5Z^EKZ%-R
MW?4J(>H2IG[3=9O6B_6J;RB2(1_D(4D_'9[E5)[7B;\)RDT3F:9XO?/^53G2
MKBGK_[H0]0ZF"EO"6AC"F$0$6W7OWMUGM'$;>>JII_R3_H!L[H<X^C[:5L36
M'>(B9H7+?$+5OV H!FA/%A!]X9TE=M&#X^SXRY^P4_[:V:[K-MFZ3UMD;RPK
MMEFRK\R- "IQDZ#+6ZYG%ZJ_7B"<]MKL OMW]S>L\<V#[+C?][*]VCQEVS>Z
MWW9L](#MT>Q1.[3]<W;:G_O9E0^^;$^.^50@OMSF*(_,7A,G0#OC?E$I4%]I
MJU38%2KLRF)V1A$0XA\-H9S&(#DJ;=@%2@#;D^&:(6"N7D2LR%5(X33WU@!*
M M<_TZVC9ZZT__2;:AWN&F;'_^XYV[7U [9YP[MMXW/NM2U;/&9[7M353KQA
MA/WVN<GV]$M+[<W/!"#!?9Y6PB* -C/P[Y55V,B51?;@W%5VR5LK[*0A<^W8
M+M/L#R_-MM<+2Y.9>3VF+%4J$TS,^UK(]:10BC *5/(7@/:>&/2],A]S2<T8
M<L3 8>@Q_LQH\QIX?8D\L 6?5X57"%518A-??<W^=M75=O3A1]@.VVSKL]O^
M\1IUOK&_-D?WX=8Q?$S/;7>N#1HTR%:L9&BGNA/@=J7':*6HBA%;$ZG!9>]+
MN(K1T'^,,J C&W_JWB_P_Y*JBW]M'&4AWRGZJD ;'_@2-1*V]\,W'I>$:BGR
ML08B;P'B &J19\ &@,SE+6(FO.-SSSO0!H"1+_+.,5R< -@,O-!17"!P.>C?
MK[\#=BB H7]=+:G'=>;_!547;RZO)]&FPXCG$FU_QHP9OIL"7W!$5L@0L!V#
M%.0[:."@Y E,?D9F\77.J ^.A%-G,7"!O4VXC'5?4A;.'80GU[Q^Z9RH;Q'/
ML9\ZP)(!$OE!]VC7,/7)>HI! P;Z6S'BI-UE]64]R.V/.&S/_XJ^4KS),^L-
MM-/';RN1OUQ> _%E2+9X7!/0YBW(1S-G)7=_">6DB4Z&+@=59R>AJ$\8.X?N
MYE+4^U>F+R9?/27EJ!%_FZFZ_ 9#U85_&7^#1)W'0G/T(XX01][>\Q7(F3-G
M^C'P5_AF<W\&:!<(*?H7(*5< %#9R94Z72*=8E9VAGYWG[K*.CPXR?8Y]W';
MMN%==MBESUO#.X;;#?T_L%[3"VRR'@=L,ZL-#*+; W\"8I<JGBF+\ZWO>XOL
MYC[3K>D-?>VP5G?8 8W^;2=<\+!=]I^Q]OCP>?;21RMLIA)>J/N932=M #;Q
MX<JRHJ+4N4!HMHC"B]EMA+9#GOV;.[J7"6%^>R.C8;COMG)3'JQ<:4!!HXN9
M;9H5D'*^3J8M+;3ATQ?;70.F6)M;^MHQ%VE T/1?=OC%CUF'^U^U!UY::*,^
M*[ /5U5Z7IEA+]61N$B?> #9;^CW"_-6VM63/K9&PSZP'_6:;KMTG&E[/#?=
M+GUYGKU:Q&+3C N+^B?#93N#NL7K253PVH"V^VCSA49 ;  P&3A C ,N 6\Z
M9XP_K_$!1T[*XSHQ!]4-8*U4LBZ4HH5RSO]LGCWSQ)/6\,RS,F :0*7T V2S
MFP7^V<QF\W$;P $@H47S%M:[3V];O!0MRY05KF),=0X0R#6PA#LX"$,;G-S&
M_0XFQ'3N_ [V^N"^ZOCKI.K2JX[)9S4=R/\":%-WOHTB<M9OK\-(-XCS5/K(
MK I TA'0Y*"-.DCG,W7*C/;33S[EBRC103I;]#1 -OF$Z8#1!SZR<D&'\VQ
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MYAD )G)E0/>Z=)1!.PRXP(8 *%BD17G)%_DD3VF9I/,>84%<([]I\!" @FN
M->(>H0$F:3%A ( )@(/-R?=)@^1Y10T@YZNA "'N8;*!YQBDTL?P]=C0@?1
M&GGPP2OL*6EP/X-J !3'F+# IF>_AZ#TD!,R0G?).]OX]>_3UWKUZ.G] W8&
M6<%,AO"Z/V3",70+RI5/G'-,RX5G +.S9LWRCY3TZM7+MWV[XO(KK(7T[.PS
MS[)?G7J:;WO*]K*GGGR*_\:-B[Z!"1&VVV2W+&09_9/W PG1CMQVJ'RT*[=E
MV#"ES7T Z,@+^2*/_&9M%!]9(4\,+MDQHV_?OJ[3X\:-\WW$N3]-E(WG>#O&
M_8\\\HC[TC-(;]*P<;8LY)^/4F$3Z=?XA@%O*'@;3GWC7\^F U5 MT1(&7R
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MO*) 9:<B(D_55]:7448NJSL=&MT7?+0%JG8#W JXI#_FPC& #-OIL;$_H"^
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M.+W#I)-,/KJ4;AM!R"N 6[I-IRDZ!(AZXAF  Y_*I[WONDNTH<R"4MX2<,X
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M'^7')F*GT%%D$*Y%?-T5^WB.TB$-TJ-] :)XEN,-?[_>Y1'D_17ED=S8(0F
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MU3DP&[^;TF FWA=SJG$#;%GPZ3NJ)  7YEJXRG _!HJMV,@G]8+\F;'!?Q%
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MC\B W4&8C6O=NK5WH &$ 3J\]J8S!5@ I(_70)'7Q<Q$8A=QA<#W^K;;;G.
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M-!R@"K#-3B_$%P20C?HDS[%#$E13H(V.( .76?(LQ.(_0"U E.>P=^@^;>-
MU2_V?D;R14721U:A.\B.MR9P]!7D-1<D1-[3A&S^]:]_^6";]0KH$>V'MLY
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M)O^TR5O_=8M_Z= !NXC\4]>A<QP!S;S1(:_D&3>JV(V'MS_H,+K+&QE<L/C
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M'@:<73IWL1;-6SC 9D:3/&#O..?-"+.?N)I0-LCCI4Z3O!!>4Q_ML'U94C8
MVK1]P"+U%4P<API\ _Q8W)FF (ZN7Y(#YX3!A'F94\1O9,V]0<SLL4M+^,["
MY)G\4_^ ?]ZR56F/(D^7-)/R!Z$7S'S2YLA[V#[BI+T2'[[<7A<I0C]X*^*
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MA7-DI)UU'9'RL!@2HYCN/-UPJ .%4>H -USC/CCNX[@VYAX:$W%PI)&1#K,
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M=0[IF-4#\9B1H_V-#8"-NHSRDP_R<^G%E_C>_]G9W8A75&.@C7]RI)\BUAT
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MQ@FQU6^GYSO:.6>=G>WCL0^DSSG]/ "6M\AIPEV*W<YPUZ&. B> 0\ K;+;
MP(+M$--O6]+D^<>6B"E'M.,JY4D(]]$I[TZVD<-'^$XFV&$6T<.X93+CS7J3
M=#M.VR4X"_)SXD[3N@/M<[H(6/=)7$4$I*L!VGD)T*[38HC5:=K'-FG1W8[^
MTVB[L==L>W=AB0-8F*0"= .R:8Q.7&2T4*Z"E*JC*!$(UT\<!CY1@9[[<($U
M'3+3]NSQJ=7#%[I766;VN)^.?8NM;O?%ME67V;;W\Y/ML(?'V"6#W[1A*PM]
M1AMQT2V3A"='7<$$\-NS@%$@-TB&#[E79H'V)6\ML0,ZS[2MG_O8-NLZWS;L
MMD2\PAITS;=Z70H%M,L2H,V,-I]B7R%>JM]+;*-N"P6T/[6K)P70)BF L49(
MJ@!"$@FL%V& U@:T8T8[0#"=/IT#"DS# P #P D/8,"]- R.-6$:$G$3+W$2
M'[_I?(B'\$B#WW"<\WJ+>^F,6[9HZ;L:3)LZU;?\<7(E%;F"9\K(>4V!=H#E
M'Q]SK-U_S[U5MD::)X-YSW_NLA-_\M/LC&> L'@NXL%@LU4;!ORIQQYW_],L
MA0X%KX&JNPR0 #0W;]389UY)D[2CDXC9V #:,:-^_;5_LW<FO5$E0GRTV[5J
M(U"\AW]I$["Z_Q[?7:"]?P*T29=7IX#EB\X[WX8PHYVSX([7OB^-?=&N$)"A
M(R*>&)@@/^3(( GYQEL"WB1T5L>0STQ)=.+KP@G1YOAH I\.9ALN@!,=#6V,
M3B-T']G3)@C'Q8*//M YI0FYL9 G9DZBPW#F]UH8PX\M"'O $1"0Z]L-\1OW
M)68/61#%3@7X;#[^^..^ERP[:>!WS'[5QQQSC(,Y_*)WVGEGW\6%O=!IMP"_
M6-1+'5(V0#9VA(Z>]HU]X#Y>#3,SS4XQV<Y6^6:00_W1OBEW>0FO,C.7Z83=
M%>A'AWL:R!%[@AR)F\Z9+0A]W]_DF9#'E[&#^Y!SFG/EG1!;:S(3R)?Q2)^\
M4$X  7D!+-_\SYNJO)+W>$2U0#M#U0%M0"UVEW[JMU=>:=-G_C\ ;<7-I,>%
M&LAC?SQ/.^]JNVZ_H]LV=L;ZTV]_9Y-2984 7+0SO@6"RUWD)+*W5HJ;$LY6
MBXZ4@[>=)__\1,][]&GT=4P6--+ D]GC*E\Z%K&7/0N30T?1+_2$-DA],4C$
M3N'RMCI!44KGJP62:^.$&$!W[=S%]P0G/=IKM%7T'0#^0L=./O.=)O9$'S)H
ML,]<<Q],VXJV3KW1SN]3_XWKT1<66P<E[=G;='+T6>T(2XAB8V^8(2=MVC5;
MEN+*Q^09UUC?LGKR17H<<>A9;#2#% ?T.3)(T]<.M.LUZ6M;-.UEQ_]^G-W2
M?8Y-F[]ZX19IDDJ&DP#( _A-)R!!E%7ZXDE$^I$*^-0'<P2TW[%]>WU@#7I^
M;GD]!+:[%PO,)K[079?9-ET^L_TZ3K/#'W[1+AGTA@U=4>@+(GGA0+/*IH?
M2 2#0IG=;P5!:,0B:,]F@_B/5P7:TP6T9PEHSQ/(7F0;=E]N&PIHU^]28'6S
M,]J ?V;;TT [F='. =KL"_Y- 6U>]P8HIN'1.= A @!H?(31,.@@,?AT:O@"
MK@O3 0 RB"\:-ATOC2: =8!XF/OHH&E(W$NG3'[P7^6U#KL^A&Y0IC1P0T]J
M"K3#T.8";1K)NV^][8O@,*P +P 9]P;(QJ#Q/,QO.@.V=7MIS%CO.#V>R!M9
M#5X#92_K3]071@"_P&O^_!??NYDT2!^02%X A\S(4A:N ;3)"WL[L_4<LX%!
M;PMX(Q/RRQ9\WQ>@C3SH; Y)@#9O(5:EO_ IPE#VZM;=&IUY5I49(#CJ$GD"
M%I#MT1K8_4%UC^S_5T0G$J\_T>G0>9BP"*?CH;VP^P+;D:4)]PD&F5F=PB8&
M\SO-Z6MB.@+T$GN0IK 1,&TI#;2X1AC7 *OXS?.!!Q94]>C1PQY^^&'? HP%
MG'S"O&'#AKX#!5L TMZQ(P%Z:=?QYHIR D"Q!;1KKN%60KOG56VOGKUL'E\[
M%5%6RDS'1O[]+19%TI'%<RR&PHZ01L@1?4&N+,)DH505HG@U8(!$M6 B9!J_
M4\1B6=Y&4![2IVQ1?NK[H@LNS"P&#ADGQUJ@G:%O*]#&;8*=KTY3^]U6@\BP
M;\QJD\<3CCW>[KSEUB^NC5'2Y(T9;1@7DBCWZERM@>*FA!T0)G7#V\[A@X>X
M:QN3#)0!>5$'R(HWP0SJ<,=*$T";=1%LE8=>TE;02_0-?<6="__C[ !?R;G\
M4C+%CM F UA^*2?$EV5Q#2'MZ.=)G[X=QK>\T_,=?4O0-)$.,\PLI,1N\%:,
M/*-?M'/:5H!M%EPSL*8]X'+"+F*Y]BZ7?#8ZL:<.O#D/2N4_K4=.4;Y8RY?\
M)@[D_/\+M%L.L?H"VELV[6T_^=U+=EO7SVSZO 0,$#WI99(1ZT^J )%A]KW.
MUSW+=00D?R1%[CIGOETX?HK]J-]DVZ3K!Y;7=7[&3:-_I=7MRZ?05]K.G>?9
M82],MY.>?].N&3?=1J\J,>8=Z9*+E58Y@+J2Q38R"FRQ5ZECL!4K6\42 Q_0
M*;8"G;$71@9H+Q;0_E! >Z: ]F<"V0MMPQ[+?%9[@R[Y OG%5M=]M 6T>Q4I
M7P+:O06T>RP1&%]H^R1 >UH ;0F!1EE*GO0K*?9ZD3=R*5H8Q^J -J]]4?CH
M].D<^>V&6HV!#I%&R7[&+&;#5ZE#N_;NPU13YCG\PFC(=!H8@MB*BKCI4&@L
MI$UC(EW.:4SI_'"-U\2 %O;<1)D98:9G$="9-- &. 6HPB"%48(Q2AA;W 08
M$8?+ 8LB1PX=YH!U%SI)I<V,*8 ,8 ;HYOF8%>4:<5QW]34VDT$ I(K#I]1?
MP44EKJ4RL[<H_^4 ]:1ALV7<$P\_8K^4_ '2 >PC+QP!VYQ3'CH-=FUAG^?\
M%.!\1\8'UY'H7.@LO@^N(X0!GAET,.-$A[@RO9>XB!GE)QYYU.7BBR!5G]P/
M(POJ$5<2.BVNG7SB+^P?U_W=71D >,S\KERVW&<YJK#223,S(,',@-!IX/X!
MT.?C3>@N !3]IDSH,WH=H!OYAVL6BWSX"%%:5N@3KX.C8W =60/307V!"4\Z
MZS01AIV@G+FKYX,(8_8;QNT$X,U'8MB3FD^-X]_=L6-'>_RQQ^WF&V_R&2A
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M2LP?2=/7/*,]U.HW[F=;-NEC/[WR%;NCR^<V\[-DQ($.>5J9#$H:F7/R(>+
M+32!%?I!5\J+D8^5T1'Y^7;#M(_LQ,%OV-;/OV;U.DZW>CWS;8-^E=:@1ZEM
MT7&1[?+D##OJV:G6JN\,N_>]Q?9J285_O(9=2R1JQ0\@*E"Z^3H2RGPY,YP
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M3C_#9WG]8UE!2C=K:Y+S+^1G;9P0;[(!L6SCMR:@C:L9DV]!F30RD7".^QA
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MKB-Z)@!CN@UDVW+R>ZV<4-IUA+9 >Z>M1YL%+.,ZPFYB0<B.M@%6*)4.I?.
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M)EU1%FC+?M)VOLM F[9[D>SC\!%5@39E!9PR<7&$VBH3*Y05>Q% ^\:_7^]
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MSXQVUO=5><.0U)2]4TDU4)2/KVTQVT2'#A$&.&"!5 #J4'*8O-$P"7?@I7.
M"J-S]O?.=EQ*IZ:N(Q@E#!2 ^B$UQIC]_6C&3+OCUMO\(S$88^X+4,K] ="(
M Z#-=69,\0_V5=YJ/#0N9NP!NF$D,+JY'!1GW.N&(\HC8@]L@#R[9I 690 0
M1GZB3)S3@3!+>^U?_NJ?72<NB"]#TEDP,Q\## QTE./;"+2_S'7$TU69Z?@
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MD+RB)[PM8/,& 'RT'Z]KR=?K/\E;-M_5T-<"M&,?;19#UFO6P[9HV=&._>,
MN['[A_;.0O:ISH!G5 *<Z_F3@BKG8BE]F9ASY8%[,;?<6T8F<3<I4\=:"NO<
M.R$=LT";^7+N!F3S-U,DTN.8!=NDR1^*"1,(P*;B$)XSZ>DY'?@$>P]%<MY[
M^;9;KT^MSG,?65[7>5:W[W*KUV>EU>^=+Z!=8'6[K;(ZW0NL7K]2J]N?#]8
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M<((<I^5D^YWO?$?^_.<_6YQV/*&#/LO(GI+%I2*':/X,("A_"J!&B8$&7GR
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MGUM/476?MQ7FS=;ZY?G4+V7!IF&G*!MY9."$;(U"Y=@CH$V>E<A7L!,L1\]
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M5'=K5J]6_=X%M*DC[#D@%:_I;;??;C':.TOKO]FD/XCE\<./Y.&'_BH7\O9
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M6[IW[RXOO_22Y<'!GY/),<I.L3<)FGZ8\-"^M6"!//?LLW)MGVO-/KDM1;8
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M7R.V4-,"&-B6?&OZ;M#.^?9WY87G^BE(^W1<)\0'J'C9 -K<8YVKI@4X)1U
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M2FWY;,#=M[_];3GDT$/,9E"7V!*><\HII\A55UUE>0#8KERY,O;&IC&$?6
MB'UY^)&'+2TZ8%]MT\)QU*;80$'U\<X[[[1K"0F#*$-E5:7E/UQ7E&/:M&D&
ME+_UK6^9W0),D7>VO%WBP\/E*Y;'[G,=H-Z1,9[F__SG/P;4#U  C Q/._TT
M \'4+5N\^H28O#'W#6L#C:E+!G&\@7A3P1[+3O/J'WM^*(NU*!AFX 9( ]0#
MF&@KV'EDX4#;;;/I='3K^@JS#RU=NM3JA@&8M6N5*VV<NCM$VS\#%]H']0P8
MVKAQHVS5009;0IX ZM@-Y.%IAP$0]8V=O_"""TRNV-7#M#T[T+Y=!W_40_Q
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M\-&EA\^P ,WV'=NM_C[^^&-; (0/+?_PAS\8\  L46=TL R>T$?DC8ZTUSI
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M,9]\XDF+V?_GX_^41Q]]U-XZH9\,>"^[[#+SRC*XIYYHA]X6J5/JU@$J(!L
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M;Q;"0-OK""+OGG^(?< [;U_H;QC8D0]_X^C]#7ET'>$Y/!]=0]]ON.$&TS,
M*(,%OA="![C/=94\DI:7D[*CK_3CDR9-JN<%#N</"A]3'J[GV=ACY$D;]+[V
MZJNOEH$#=\5Y0ZYC88I_1F,(+SGM@O9$_I%%N$[)$V\HO"S(/0#:=BC+EBZU
MCP^9[@] [38+G62+K?*/)-%9WA#RO=./+KO</K3D ]"?W_(S6T&5 28S0:'O
M?-1+N\4N>5[8NLZ15QQVR)_!$@,AVABZZA1NAV'BG)4C3GY0A+(%?6J=5"G@
M9HU^53<%K'7FU>:E)D 68+BLK$ZF+BZ1Q_.62,\_39:O]^HO'7[\M.QWQ8NR
M7\?ALJ\"XGUZC)&V?29*&^66NI_2=;1$NH\+@'8Z7FX%V=T*]-I<V;]+EK3K
MDB'[=\ZPN;7;=,J55EU&21L%ZVVOG24M>LVT!6\(/4GMEB<M.P^3 [KVEQ.N
M'R 7W9LIMSTU5;+FKY95%3H*LOS62K$R4&2>9KS?D@JY??96N3AOA9PX9)%T
M&+Q8#LA<(?L7K)?6!1L5*&^0EOE;I+4"X];Y)0JN2Z1E;K'%8*?E;9&4@G42
M&;U<(J,62TK^"@77&V6?_&)IFU\F:;EEDL+JCR.+)))1+"D*OEN.+I4VHW9(
MV\R5LM_ =^6(_J_*>5GSY*:9"^69%=MD9D6U+%=9(TOD6EFE!EGS7@?B#D^D
M7;_^=DM4ME<X6RK:CZEP#!^&[*RSS[*&:Q\CJF(11^R>MJ9D7HVC_+#%U*K1
M06EIV##'&#R4.[RE8Z/Q84P8^6,D,124A6VXPPHK-.<H(X:O7;MVL9$HC-'R
M]-EW@XV!!FS%QS@[0^$&4Z$@DUE$7N[W@L59\\&;@S#W9 *Z7 8.P!)Y-QVL
MV;$R!@3C0>=&0\<31Z,GO\@+X/FWO_W-@#/Y]?Q!R,2!1_@\1,B&Q>9IV3&L
M]C&*YLU!E#/U1">,H<*KY4 ;'>2C$O\XCE=R>#$!Y%Q/?@%AL;K6?>(LR3,R
MIX.@3EY]]=68''='>.\ 77A#J4/ON- 7\H\\.(:I0PPE'FT&'W3@$,^)9^2"
MC.C@T2,8[SDZQCRZZ(+K)J_OZ33YH)<W#]0E]1L+^8G6L]<AYY@A!N8ZO-L^
MESO3!3)K#??P%H3?^;#R(04J4R9-MAE,R!]$O?+6QG6<\QAVUW_.HX\-$=?$
MUW^8J%-F\N #(KR6S(P!@$(? %_L$R( N&+ QP"*^G1]H;[9YS<Z-0 <'RB=
MJB"";R&H(Y>AMS5O>]0==4F'QF^ DXLOOEANO_UV&3Y\N %4 *GE4\OH,O!C
M?F,+NTR<_#KDY6$DV#H\F(#[<+[8)T^>%\X!@L@/NL26MN?W>1G8)]_<P[WL
M PIY!F7 0XE7SO-.'EWOV(9ME^>78V)G 5T\VVT6>HT- VB[1]MU)$S<[^ 0
M[S%@\9Y[[C'01KUY/<&TS:.C=>?U=MK)P8K 7,LUG$,/N Y;A!>;N8NI>P X
MTY820D3H";,U7:+U%QY\ .+8 K0]S,\)N;@\. ^['-@2]@'88^!+'2 #[+2#
M0:\[UR7:)R%"@"'*^_###UN(B).G#3$ ([R$\"6<,,@9^T$Z/(O0,^K![8?7
M85CFI.?YA_A]U:I5]N:#MR. -G2#/),^:6/'8=<ARL#S<")Q/5N.R0N_NVYQ
M+_MLW?9Q+X"</@";CG/(\T*^$N77B=_P: .HL<>D1[KDE>?BT<:Y$7;>>%MS
MBB]_8PF/-C)B0,'S?!"%C-AGO01"!?W9L3)5:Y\3_3!WW=IU-GD ;]8 UM;'
M*&./POM'J]ZBS]@Q9W0=@,X"2S #3#Z6!I/0ANECD2UR)W_H%\=LD1%OOQBD
M$6*"H\8)6;A..WG>V?);(EE%B'/&=,'E>C-<45<M93654E)=+J6ZK:@+%HT!
M'&[6?O>]C562]>I:N;_?//G17?ER8K?^<M!5_:3=-0-E_VXCI6U/!<R]\J5U
MGS'*$Q0L3P@^B.RN0+N;GNN:)_LJR#Y  ?:!G4=*>^5VG3)EG\XYTEJ!=JMN
MDZ1E]^D*TIF#>YI$^KPBK6^8)6WZCI<6789)RZN?D0,Z/B'?^-E ^=V(=V3.
MNDK9H+I1I.A@BS(SPX[?6B4/O+Y=KLA:+2>_M$0.ZK=,V@Y<*VVRMDBK@B)I
M,9KXZD))&ZO[XW;J\4X%UX62DK-->:O8W->C-DC*F-5ZW7(%W:OUFJW2LD"O
MS6'*/P773/F7JP ]ITA:9FV2UB-62_OA2^2881_(MS+>E>Z3%\I?WM\@(S<4
MRGP%V83]4V6E.J IK6#-?6TDX!CE6JT %;78MQQ[IM,-$D8>@.8QVO8:54?V
MS(@0_RJ\J9BIUP!A,#-IH,0T<HPQS#Z&A$Z-D3X*#2"[^^Z[+70 0^VODZ"P
M8L/Q'1?[E-&!-AXAO!>P&S\:DW=BR !PA<?(@;:G%29_GE.E LV52Y;*Q+'C
MY)&'_FH?Q>'=)FP 8.7 V\$T#- &8#D8]WW.\SN#$@<R!GS5$+FAYC4B'Q=A
MK)AMQ3L#)_(;ED4\893QTA$2@4SX (A%@@!3L'>F=*R +( V\;SU%OG0$;A_
M5,C'=80.,,<I]Y &G@7JV?).)QV5M7<\O!(F'V$Y0N27<^%\TRD^]]QS!L(P
MQ 9XM<Y($YTA/61#^AP#B#XK="3\7&05[D#PN/ AU$,//21=NG0Q<$.("NDS
M@PP@F[KT01/UQC[GJ','X3X##>?\/ SHQHM-F_B6RHS%B)Y_ZFEY^\T%%H;C
M1)[(/P,!\LPQ8(UCZA:B'.&\QY.7-5SVV+GH!UT0,F !*I8&YU4K(0)X-_$,
MH8/N+?+V&]-+93HS.C8 FX<=L>6C.#HN.BGTELZ<>O(.%=U#IK1W7O_SW0 =
M&!Y= (N7$6*?/))WB*WK-^4/RP2*UR$\<X0J\6J8.L7+BYZ@1V%[P#%YI+W!
MY(_SKK_\1IGH<-ERGG)P'CW!U@#P*$/85I$7\A_6._8Y%RX7^PP*:)_(#'TF
M3VSWVV\_LT^$X^ ]#:?EA P V*X3E)L0"#X<O/RRRV.#*+/!H38*Z'800OUQ
MWF>'HEZI7W2 <^@$^L$"0TS#QY1SS->,1YLIT%R.U#%Y1HX>.A+V6GN=4@[G
M,/$;;YD Q+1GPB.H ])ERS.<_3Q F_H@'IKVBWUTV8;UP6/ Z6?((_V/VR;J
M]KKKKOO4-Q[(-)Q'CGVPYT3[)&V\Q<Q\@]<6X$S>D(N#-M@]I<C'R\ ^>L5U
MY,?/<\QOG.,>8LMQ!N!!9R77^'R2+_*"C!O2$W24$ FWGVR1'_GD8TAL;GR(
M4EB&[)-V^%QC"  ]9,@0<Y[Q3&3/EGJ#"7<"Y']JKO=0GP/A%!DS:K39*]ZL
M,$^]>[;#>NUV"1WFG'];0!_'EN, E.]J]]2!RP1Y,.CE;0UO.@BI(=0P/&A$
M!L@4V;L\7#Y.#<DI0M7!=..E>@W.U8I:-?8U"K(KBI6+I*I:1^F*_B@^9HYF
MM$F?/W=YA3P_;IG\_)^SY(([\^2DOL.D0]?^TKKCBY+::8"T[)DEK?N.DU16
MD%20C6<ZK=MH:=4U5_;!FVU .T.!=J:TZY(M^W95<*Y /*WK)$GI/$4BG:=*
MI*L"[9XSI<4-KTJ+ZZ=):O=<2>TX0-)^\K0<WN,EN?[Y>3)Z:;F%BO!Y&"]C
MF7DS8T.I_'S*>OG^D!5RXLOKY+"!V^6 D:72)KM,4K("H!P9I3PFRJ.*))*[
M72+9V_0W5G-4'JV@>_0F21FU3H_7*RL YYJL[0JR=QCHWD_3:)>]4=H-7B2'
MO?R^G#7\0^DR8:D\\.8Z&;*F5%ZO$"%RST)%5(9,9%]162[E:BBKO1)5YGPO
MQCH\"=I+HRA1!0/. *YT"HP@3S_C##GK[+-M GR6FVX./D>95\S$^+&X"9T&
M<8B,Y.FDZ&P98>,-H&/ B.!=Q$#S0558:<-&VA4:Q><\QS"_4T;B[1A,$!_'
M\V",-LQS87['FT#<%5Z4<'QLV,!ZVKYOT\7AZ=53+!RQ^.-/9.3087+/G7=)
M9VW\%_WP?%LB]PQ&W=K!X<&$B>.%6<"%&4D<E-N 1,_C.<4HT/'Q"AXO&1YL
M.AQB2'FMBB%U<H/J^>/890'Y>8BO_QE@G7/N.5;N;ZA<J!>85\0^RL=#S3EB
M,)FE(KP8 .2A(WQ$!1!G[E7NX7ZV,'7-E(/('D;6R)V87>HFW$E!Y)%RN+PA
M0D>8!@YP3MVA-Z3!/FFR3U@ QW@4>97J\8J #LC+[N3R"'.8T"5>._-1#G&[
M//L*;2?G:0?^C3/.-" -8#ZX_8'FJ69Q(H_+#C._,8<[@R=FFV$ AI?[')4-
M^D&,_SCM+)8O72K5/AVC4EB_G<@3[99Z=X.>*.]AXC>7)^S7\S:"A6[LE66(
MF*.;U4@)7[G_WOOL]2P?%EURT<46(@((HU,"<-%1L:5S0U=A]NF\F.N6Z<8,
M"&E'18?%/H"!3HNV!LC!6PD(XV,O!D9X(#V.UXE\>QOT\G@Y('Z+EU7X.B?D
M1B@*WG(^I"9^&ETA5,4!#_GTP3@ QP&<#^@H ]<!Q@#JW(OWE.GFB-U&3WF=
M'![\>A[8DE>O.XA]MUL0Y< +S4":-H].,RC 1M)6L8\X @#:W.M$>C!EIIRD
MZ<\@+[1YPKN8:YA7Z+1- #,@A/IB*6OJ$V!"'5.7#D0 *=0];1E;@%XPASPK
MG3JQDB,+.?'6B7 ']\YZ>T3>V*Q$@##>3H7KC;P3HT^L_0,//&# E?2P <@#
M$,LSL ,\DV?S&]?A^0<0A?7"B8$<SAM"V+B?M+!-W(^\D?_,F3/KU6.\/E%7
M_.YUQV^4#T:'T65BD;&U]"OH.\]R$.?>>'3+/?& .GZ#K>TH<QWWH6?TU;R-
M9+#%  HP2CX@\N=V [FRY3A1^?F-T#W NO>%E)TW.<B!@1ZZ["%LB2B^KAI+
MA(0@%][:\"RWX=0?^DZ[)$Z=;RP@>X[VL[ Y&D./HQQ,4\EB8"R*]-.KKC8'
M 1YK]/AH^ESZ4[7%;+%=;-'M _9O)^WVVU\ZM%?[S>_:UKW],Q B7_0K.+8(
MM:3?16:>KS"11_0Y+&OVPVV](8K0K>)?H:M"W>C6M4FH;69NP)U26;Y=:BKU
MBEKM()@G+RH!JIW5&Y<65<G4A<7RCU$KI-O#,^3KMPR30[KWD_VZ]I.6G5]4
MP#Q$4M/S):7G>$GI,592NXV2EEWRI$V77 LUV=\X3_;5\VVZCY66W2=*BUZO
M2%KO.9+2[16)=&*.[<F2HN=2KYTF:3U&2UKGX1+YR0O2OML N?:%MV7<FEI9
MH=G"MX#*\ 'DT+4ETG?\&OGVP)5R_, M<OCP"CDPIT[:Y%1+2D:)1#(56#,]
M7P$<W6>U1]A6="Q5\,VV4(^W*/C>I"!<M\:;I05+JNNY#MEKY&LC%LMI0S^0
MB[(_DI^_LDZ>6U(JKZA<EFK;)$^8'6NFMIB.&L?*,JFI*)6ZZ&P,2+2Z&M"(
MW.U4H\D;@C/'SG@6>#4+D&7DCV%A(0,6"?BM,LO?-C63+D8:PT,8"!T3S^:C
M%3H/1HK$;O$Q$*]E:.2\#@M[09PH TKLQL3+ZLKNOU-&8KJ97HM7J#R7#TQ8
MS0S#S3Y,GMCB\>*582*@#;OALO/:\&NB(-NI;&>);%BS5CYXYUV9-&Z\//?4
MTW+7';^43E?_U  W'D[W:H>]G.[QQD/*JF(L0,,(G5>#S/-,W#@?9_%Q)Z$S
MX0X (H_.;FS9A[P,,/MXB/$H4'[>%MQ[S[VVZI:OX,G,$M03NL"6#G3:E*F[
M/-J4UUF)&0KXN(1E:+F'K\*Y[YY?WQW;YSGV+-4QMH2"4#>>QS"1QS#QJI%.
MCY@X[O?Z(Q3 ZXUC?N.5/>=('W#ANN,Z$B:.PSH33YS'(XA7C(_BJ /F<V9I
MXTLNN-  ,W7' ,G#1?!B$V\=KE^.F0*005?/KMWD-RJ3EY[O)S-4ILN7+)6=
MA45J/G?)@>>&]1IBRSG8]=#W(;9P?!G#Q&\QUF>81ULO9\#D@R:(>$@6E6#9
MX8GC)\B008/ET4?^;C&-O*J]E"DHSSK;0@L :G1H>$,YQFM$IX57"4#!A\9L
M 0N 4MY*T(E39]0G'2J=%UY WB+%ZX.7U<O%[V%@"O$;Y_T:B/M<ABXCB'.\
ML0" X;'$@XX^$H_-0!_O.GD%3 ."G+T,=," .SRFO/IFP$@'S" !0(BNDC\G
MKR>7._OHI -AV*_QZ[%]V,(''WS0=)R!'CJ-C<9+ROS1.![\'M*@_%Y.?X[_
M#O&\S9LVV^))A('Q$2MSS1,JQ, 80((7D#KT5_%A@,T'D]S#&P]6U23<B!D;
MG)A7.T?!,''1R(2\P@QXR3\?MS$X"-MR+SMY\[Q[_<;GG<$V;R=YBX>\Z3NP
MYW@8 8LX4_B(#3N/S- M['B]F2M"Q-L&WEK1]W /^:1O\'Z"T 4&VN[,('_D
M-TSD$3OLNL?6]<V/Z;](AQE1_OK7OQJXQ*8S"&&@AEX!I@%X>*O#GFZ8 0!
MCX$<^<++C">:#_#"@Q:(O!#*0+X\#\Z0[_,;US#H9(86])^TD0$RI&W2'_,&
M*!Q"R7V)Y+"G1"@<;S-Y!G7E-AWY<_S$$T^83?#X<)YI,X4HA^V4$W-5KU^[
M3E@5-B\G5Q[^Z]],MZ^X_$?F*"+TB3>1@&QLE8?$8;O<XVVV3 ?/R)Z!&C'8
MS"A"OGCS09MC<-80%G$.$\?H $P9&J+(-OVM4.]UH(WJ!TFI,:PM57Q=*'55
M1;JOOS(K1K4:#U4T'D"RJ"B>Y+<VU<J0^>ODOF'OR4_^/$5.^_D0.:#+4]*J
MX_/2)CU#VO0>(RUZCI6T[J.#J?NZCI:6W<9(J^[CI%4Z\=Q3%$1/D]0>TR65
M.;C[O"IIO>9(B_09TC)]BK3J/4U:]9DDK7L42-ON6=*BXR!IWWVH]'GA?9F@
MZ'J-9II! Q$_1&P-5Z#=>]QJ.7O@"CEZH +BX:72+KM:6N=4!;'5V462DK?3
MF-4;([DL.%.IS%+J+*G.3"*ZS=%S67I]3K&D*2AO4<"JD.NE]8AE<L#@3^3X
M81_)!?E+Y*:9J^71C[9(_H8*>4^%@DR0#5,,$G=D'SK2Z0&N588&N&MIL%I)
M"L"KV:+@CFP:258/>I]7=%@9.(?"T\'QZ@FO,1[&-^<U+\]_8YZ\,6^>S'_S
M3?/\T#DQ\N<5%2-%&A<&P_/IY)U1N*&SQ0C#E,?+%[X&0\?K1Z9* Z3B5:&\
M,-/<$<,-A\\CDS"0]71A\N'/ I#0V6 $6-$M-B%^E$J+=\J*I<ODM=ES)%\-
MP'-//R-_^>.?Y 'ML%BTYA<_^[G<?,.-MG@+BYK<JH#Z+AV5_TY!+]>QG/-@
M!<1T&!C%\ >:$.6$G<@3,J)S()\<.X6OQ1AC_"DW,F$N7>J&16Y8!8O5#F-U
M]?I<6:#[+"]+FA #C*H*[1SQ,"AA_%B%DM '%E1P)EU6H9PW-Y"Q/X_8;)9N
M9C#C>62;:!^B/'AN ,[<ZW7%-LRD3^= APPX!O2X[B,7TF3?ST$N%S^&PL]V
MHJU\K.!L]NQ9ML 0BPT]_N@_Y \/*,#7 <6="D+O^,5M5J<_O_D68_:]/EE!
MCB6?Q^B];ZO>;5J_(2:_&/%89<^/RX'\AO4.0B9XS;Q.PO?LCF*_TV&QJUL\
MZ2QN%/,8A8BO_%F%$-#-JFOCQXZS#]^88810 <#7W7?].O9A$8MWP!S_^FX&
M[_?(O0H2&0CAA<.+2*=%?2U:M,@ 8SQ@")>!,L-.[-/>O=P0U\>7W=M!V&9P
M#_M.R(^VCNUC$,LL'<2[ N( M@S:B-5E.6X &.<H!V_;Z'SQLJ)K@)[X6$V>
MZWF'>3[,>6P+';;GA?->1LXQ$, NTE;0:72=?<#).^^\8PX(\AY.@[)Y62'/
M@^?#B0'=<K5)Q.0SB&+I>Z;FY/4[ V,&RNPS\/[S__W1ZIGI'/E@%IO O-%.
M.!D /SR+03CI+E ;@$S,KBA[OX*-#W]K +'E7I</Q+&7A?/A\E!> #(#=&P!
MZ6/7<<S >'BQ#SR/]D]_0CJ)"-U CFY3R"<ZZ7EG4 #()"_D(RQ;)WX+]SUL
MO3^*OQ;;C<T#W#.XQ-O.;#SH% ,3!@SH&6]WT#7 +XX0'#\,NHCW)X_H:QCL
M\1QO#VS1+3A<;O+FLH9]'SVC;Z3\7E_H&#+@//*C3)X&:;H<./YOB308 #&@
MY'DN>^H-?4=./)LZ@NS96C9;197'*K//MT%V+DH ;KYO>?^]]VUU573VN6>>
MM5F1T&VW33"SY/Q,;31\^ZVWF0T#5//F!9GS5ILWHN0+QQ;M+4RNHRZ+AN3!
M[ZY##5T3V:XR+E9]P0R6JD&N4*[%\PKD9FGV&C4N-7BT=5M;8M[8NLH* QN8
M0: *XR'&):RX.&M]K3PS8X/\O-^K<LGO\^346T=(AYY#99]N(Z1-]UP%UOF2
MUFV41+J-5>8#R:D6&A(L8#,GF%N[>["<>PL%VZWZSK;91_;M,UGVZ3E&T\F6
M=CVRI6VG87) MV'2\UD%VOI@Q?D&;'=H.5?I-E.!]K7C5\M90Y;+$8/6VFJ/
M;3-W2JN<4DG)"0!VB_P22<LMD12;.40!=C9+IZM0<J*<Y5PCJ7D5TG)4B;3.
MWRS[9BZ30X9_+&=D?B173UHJ#[RU648HP'ZS6L&(/ALSA6KP J".CQS+=:="
M&8&Q1*56C"(7W6CEU&H#JJW0TPJ\[0(:;^+*:HBH7"K9&PS$N7!C^5\;3G,3
M"DUGC"$)Y]/+QN\H<WPY_'<:+!Q?1H[C[_$&Y.?8.D-<#SLQ!R=QM8!M ]D
M&$BW=$3VM;02X)3Y:%EZ??'"138G+9W=S!FOR/1ITVVJH3FS9LM;VE'A,5JS
M<K5YC1PLL W7H9>;K>>)/))_OY;C</F\')SC7B\'J][5\Q3HK@\:8,IA9?%G
MZ#[EY1SEY%[*]RF@QG[X6,GNUSS"X7QYVKX?RUOH&LI%)^/GPA2^+GP_%*Y3
MY,*QRS(^+8[CS\43Y62N:(PZ\TBS)/)\[2"H2SS[,*N8X3VD/OF=E?P(O4D$
MKDW.>M[U)YP'RD'>T7W/,X0<,/[\!OD]X7MW1]29L3Z3D"<&C.BJW:_GP_46
MJW_-(Z$E@"K"A?!BHLOOZ "- 1E+ZK-EH,;'<736=)H+%5 #$!@L ;;BZ\+K
MBBWE=-WD&M]"B>Z!V.=\^%K2B&\' !#L2**V!%"F\P=\D5<&HG3\O$D!B !V
M ;^ :IP" +XPX('(%VGS#)[ESPXSY[P^O0SAWYW\.K\FOHS^++:>+OO<$[Z.
MYY!/?H.H6P;)/H<P=8D>+UNRU.P.3+PUH)F5^79LVVYOK,*QL4Z '( VOP4V
M0/."[L21E\WS";-/'CV?SA#GR*^7Q\OHY/<Y>UV'9=H8(DW2]OPD(D_?ZP(.
MYY_[_9F<0];4O9^#V ^GSSVT W2-00. $X#I(!>]PPGE U%TDV<F(M<WEQ'/
MXACF'H[]^6S]',0Y[H.=^-UE&3[/M2X'+[^?_V^)M'A.N&R>3]^/I:^;0,<T
M_\HL:8X]M;>LT4NL7U)=96ND]JRD>*=].,FZ =@I'#^S9\ZR-[1\>#Y]ZC1S
M(&"S^$8%4,V@$%L0SE>8R!\RHJ[CK^$WSS]$_EW&#<DJPL(OQ&:7Z04EFF"9
M"J8:K[6"O\"+[4!;N5JY2B$Y'ED5".VM0KE$F;$^4P&R9/O[1;4R;DFA///*
M&KGIV3?D]%N&2?O.+\@!W8?)OMTR@NGZ#&Q/D&!)=@78O5Y79H7(UX*%:])G
M25KOV<K3)2U]O+3I-EK:=LF5MIU':CH9TO::(=*NRQ#I]<Q[,E61-5YYRLZ@
M@=#^K'4[Y;J)J^6;(U;*42/6R_Z96X*5'7,+%4P729H";9ME)'NGI&6624I&
MM:1FBJ0JL$[1;62D\@CE#-%K1-IFE\L^(S=*NR&+Y-@1'\L/QJR06][<(D^N
M*Y%)Q57RB=8%+[ 8$U4B&#S8?&D*T(;9I[Z<]5!52BM&#4<=P((A"Z\CHS_N
M 84KV@GE0,$;JOB]B<@K#9+\AQ78B3)PGFU\>;B'>_\7(FTW,(GD!3BAPS$#
MH/MA4-)@5:D. %@P"HS*,1:^2 2='_<W1.2'<B$7+S=U2</W8]]R#>>YGF.7
M8Z)R?!8!R/CHB7)9.77+.2_S'JIEC,+Y=6+?.?ZW_X9<#SR]L)S"Z<<?0ZY_
MS+R4D/0T,J .\/ZR: N,@0>$N&XT2'H_'8BSR3-:M_:S/I=C[_@\;YP+ZT&8
MN,8Y$=D2Z=%ZM,Y+Z\\Z)]T/?M=[];=&U:E>R[V4%3TNVZE 5O?1;],WS5]#
M^8@GKG-Y4[:P#-CGM_CRAL_[/7Y]>-]UP&4&-T2>)C)W<,X^YW='G@?G\+/]
M>9SS\Y _BRWG&TM^GY?)T^68 1CMGF//D]>U^6H:('ZG+G?;GC5-KG%=99]M
M8PDYDD>7@3/GPN?9]]\X!['O<FPL<:_?_]\0SPO7#W)%OIX/SH?)Y>WW^;V[
M(ZY!+@[2V;HL$A'GN<>W7&MU''T.Y\) T--AZS)L*.TP<2WLUS9T#.\)->;9
M$/FD7$[H)3;&WJ)0;I49_26VQFP6Z:+CB2BJV[8XC?:UMJA689'9Z;*2LL S
M'LW7[O+';Y27O,'Q92>_\;8BOASQ% &B&&OB%4SOIR"ZAK"&.@7:"@ )'\&3
M;5RC^S6<XP[-J/ZO5N8#2L VGFT8P$TH^<>*OO/?WRJ_'_FF7//7R?+-7XZ6
M@].'2JN. Q5L9TE:S_&2VHN915Y1T#U30;>"[#[SE><9^$[I\8JDI$^6E*YC
MI$6G/&ES39;LVVFDM.\Z0MI</4 .Z#Q8^CS]KDQ?J4"?-J%YJ-"R$Z<]<FV1
M]!ZW7,X<ME@.4[#=-G.=@NQ-DE:P32+YA9*:QS1^RED[I45FA;3(J%4625-P
MG3I4]X?42BO=MAE6)?L.*9%#!FV6DX>OEO/S5TC?F>ODH8^+)&M'K<S39^%!
M)]H7D,WSJ^C@$#J=KWFPJ;R J9M=,XNP0^6K3.M4MLC<O-KV8Z,)Q7"E<&*?
MQAD^YPIDQIA'-"='B6<Z)R+/>T._?Q9Y.>/O]W3#C8%S\8T&XIP;LD_E(_Y0
M98<Q@*WSB?[.^2K.[0YP-4#A?'J^PT85(G^)@ #7<IXM]W*?IU>O+.PZ:U[)
M9ZP,D)[G.!8NXK?J%D#FH#N6!N>CZ7#>9<NS/2].[#O'D]\7OL;+Z.F%[PM?
MX[_%'X?)?_/S?GWX.GZW^O?[^4G+% ,N>THDH??9O3!)1-G.(T]]%L]UXKE^
M+IPW*#Z_D)^+/^_$^3#0KI<??H_FP\YQ"H[^;O<HV[EFHOCZ\K)P/BP7*'R^
M(1GY;^'SB<XY)3KW6>3YB"?.>;M+1-S74+X;(K_>]\-I<QZP1KOW]&);JT/;
MW46)'AD^QWY(#VCK#K0YKJ<CL!)YB.]?(/(1MJ7.?KV?YSC^7HASB>Q<(O)T
M8/9W1WXMV_C[V(:)Y_O;BMT1]W%-.%TX_-N>D.L0:;#U?2?2#.>5?;?]8?+[
MP_>R3_K4@:?AUW$<OC9,G-_=[PU18^[C-R^G$WT0:S;0#SF9O71]=-+]IK)1
MGH>P7':7;ZY%CN%KN-?O3T01+:KF%5:A*,B# [ 7A> L:UZGA3;@[<?\3J*:
M(?V+F+@:F(A?%B84!="]42][OZA:,M\ME/N&?B27_FZBG'##2.G0:Z2TZ9DK
MJ>EC)-)EO$0Z*Z#N,5LB?=^4R/4+)-+[59O:+Z7[%$GM,<EBNOF LIT"]/9=
MATN;*U^2@[H,DNN>?D]F+%>0&ZT7\@+0'K:F4+J/72RG#OE(#AJ^6%J.7"$I
M.>LDM6"SI!C8WB&1W$))P:.=K4 [4X%U1IVT'J[@>E"E[#>@5 X:4"Q'#2R4
MDP9LD!\,7RLW3MXJC[Y?+ME:J'D5=18+SK/P9#.XX"4C$@QBKO&0:>7I.=BE
MZI(S G';LO$^H %P(\G8%?\3-:@LG&YN_JI0HK)]%N\)[<'U#=7G[HQ"C#QO
MG\&?ZE3WA+\J]+^4*_[>AOCSH$3/W5-.TEY)M/F$[3Z^_L+<$"6Z=G?<S-0H
M>]:,U*!L]T+ZLN2S4135KV"PR,ZN<Y_)>SE% G@(1(9!JP ]. H)J4BK3,"?
M;X&S; 'GP3\_ZQS\&J1(_/9RW9F]ID1>FK->;NWWCGSWSM%R0-<!DG+U $GM
MDBVM>D^2EGUG2J3/'&4%V;UTOQN+U4R1E)[3)*WG)&G;8ZRTZY&O]XV45E>\
M(!TZ#9 ;GWU79JU48$^6-7N$LA K/F1=L?2<O%+.REXFA^>NDM;9JR22LT92
M<M<IP%X?S"1B8+O(IOM+'5$JK4=42+L1E7+PD)URV(L;Y+CG5\FY ]=)CU';
MY$]S2R1#"_%&H<@*+1C3]3&0(!Y[1W6M%"NS]'M0?K:U!KI=FLC!I<LU2#+X
MJW+V@0PSNYC<@U^;C4B^N?FK0HG*UM3\>5"BYR9B*-'YQO!7A1*5K:GY\Z!$
MSVUJ3M+>18GJJ*DY24EJ#HK7K[#.-15_0:1 &[A(A#6!#_BB =S 06"RYDTS
M9\Q^C '6_B^ E<'UH:OT)NXC/+E8?W90ND*QY.1/2N7O>1]*^B-3Y>S;LN7@
MWD.E1==A$NF2*9&NHR328[)$>DX/XK=[O:+ >[:%F+1,GR!MTD?)?MVRI,V5
M_>60S@/EQJ??-8]VH6:905"Q,I[F0>M+I>?T=7)VP1HYO&"=M,I9JT#;0?9&
MB2AXCHPNU/WM$LG<*I&1VZ35B*URX)!-<NR@=?+MH:NE<]XZ^>V,K3+HPTJ9
MLU'SKF,2RL#0Q($S83.E"K)A@+9[K9V19/C8WQWH;?;7CO!\*[/=)<=FI.#A
MS<M?%4I4MJ;FSX,2/;>I^:M"B<K6U/QY4*+G-C4G:>^B1'74U)RD)#4')=*U
MIN8OB!1H$UT,?"3X@8 /!=H6&A* 0:!?&"CN8D!EC?X+^VV5/;R$)0\M1D?3
M4,;3S$>7P/E"_6G%SDJ9OKA$'LU=)#_]0X$<W>LY:7/U,Y)VS6")=,L/EFSO
M/4,BU[\FD1OX2/(52>D\7E*Z%$B;KCG2]J>#Y;"N@^6&_[PGDQ<%"^@P1,![
MOEBY_[I2Z31YK9R0O4+:9:V6U"P%VKF;;1&:R!@%V..*=*L@.V^31++62TK6
M.MDW<[5\;<02.2]GJ=SRRA9Y84F5O+J]1I;I*&&+CD6J*#A@.%HV,+&53[>5
ML/[LDK 5U94=-L= =4QZP1#%KE6N/[Q)4I*:F (E;%Y.TMY%B>JHJ3E)>Q<E
MJJ.FYB0EJ3DHD:XU-7]!I$";( C@*6 ["K0-7@>@#UCH8+ ^ Q(!VE6ZYU 1
MD!YEPB!J],YH@#C>9N:4KB+P7,_Q!+S/GVRJD)PW5LC] UZ5"^_+E4-[]I>4
MCOTETCE+(NGC%63/D91;WI#(M;,DTG6"1#KE2^HU&=+BQ_WED"X#Y*9GWI6I
MRQ1HZZ/(/?-7*^Z6%];LE!^-7R&'#ELDK8C/SMTHJ0JP4\<5*]C>(1%BM?/6
M2\O<M=(J:[F"["5R;/X*^=&L=?*;A=MDA.;K'2T"T@$PU_'%:J4.$RIU8%*A
MLF*?.;&CL40,)I"3332BY:Q0P?%-65#!7*,G;0!C5^GI:OU7:]YQ\LT[!=XG
M< 6W)"E)34JFA\W,2=J[*%$=-34G:>^B1'74U)RD)#4')=*UIN8OB$) VSW:
M ,$@1_% .PJE0T ;GS:@T7]1C@?:?%$*&]"L%98=+R]55B3*(BT\@[FOYZ^M
MD&>G+),;GWY%OG-?@1QZ8YZT2,^12/<"B?14P-UC@J3T&"^M>HR1-LQ8<L6+
MTJ'32W++LV_)K%7$20<YP#^_4/F9-<5RT83E<F#&8FF9OT92QF^3U(F ;,)$
M5DG:L"6R_\@E<I@"[!/SELH/)JV6OO,WR^/KRV6"YN=#38.94\K)-S.M5&G*
ME9OUQ 9E_:5<Y5:EYZ- FPV>;9O53_-2I<7'\6TC"E"XR4'E83.V[ +:2!S)
MDV_":R@#,DE2DIJ45 6;G9.T=U&B.FIJ3M+>18GJJ*DY24EJ#DJD:TW-7Q"%
M0D?PJ>)?):!!\Z1_##SJ?AALL_6PD6H]JE%H6 ]H<Q5@$F"I"3 %2VT5"]SP
MFP+,VG(%H+ >5Y7I^2KS &_1PT6%53)S=;$\,6.-='UB@9SRR['2MNM0B5PY
M4")7#U60G2<=;A@GAUQ7(/O\M+\<W.E%N>FI!3)GA0X1-)/D&^#ZB?)_UNV4
MBZ>ODH/'K)36DS9*9/(VB8S;(I&LE9(ZX ,Y9- '<E;&0KDP=Y'TF;%.'EY2
M+KE%U?*&@F+N9S:1(H6\-<BD>JL62P%VM0+LFDVZW:)Y5[D!P%50[K!F@1I;
MI 8.\'24]8(J/8D''+!=%X2.\)=0&FK ASI!#20I24U,-([FYB3M792HCIJ:
MD[1W4:(Z:FI.4I*:@Q+I6E/S%T21.H5W=5*LK* 7(*P $(^J@6Q8]P':#K:#
M_2#"N%9!=1#\0- #6P79%L.L*7 S">D6,&T+X!@05RC,*I,L@E-5K" \6)$*
M+,JO ,X/].<1[VZ7NX8OD@L>G"Y?NW:X NL7I$VG_M*AYW YK,](V;_CBW*(
M NWKGWA+9BW6IS,*T.<QCS5 ^9E-I7+%G+5R^/A5TG+<:HGD+9=(YE)I.^P3
M.6K(Q_+]K*5RX]1U\L@[FR5K3:G,U>SS$24+[N#))A\E6L:J6H7;50JRJ_27
M6@78_%*G Q/F%6>V$'TH0)MG&\!&8"ZT&-"&]2+<W>[=5QER&9+#DPW(!G1'
MBY&D)#4MH:/-S4G:NRA1'34U)VGOHD1UU-2<I"0U!R72M:;F+X@BU0I\JQ7N
MX9TFE,'G$ DSP&\7[_J,KT[!-0 ]\"-'?;'FWM7_>G&,[1_PG)6L2A2,*JR$
M =QU"O!9?KRNVE94+-+K\?"NT:1FK&(Y]\UR^\L+Y,+?%,CQO?O+H9V>D8,Z
M/BW[7O&D'-:YG]ST]#LR6Q&R 6T%]97* .:7-I=*Q]EKY)B")=)FY">2-O@#
M.7#80OE&P2KI-FV3/#BO4(8O*Y<%)74&KHGM)HB&+2"[6,M14ELMY3H@J*[9
MKN4HU/&##@S(/PO,&"2.2B=69BTG(Q0O-^((LYWG0N7@3HO_YD-1F \H23'X
M-4E):D)"J9J;D[1W4:(Z:FI.TMY%B>JHJ3E)26H.2J1K3<U?$$4J%#!6*&BN
M4(@'='2O-8 /(&@8,LIDE"GH@E 1!]@*/'5K(%KOX!X8AS8@DO1("Q!?5:=/
MJRV5JMH2!:R!%QS06E.M8+^J3*JJJ_2W .B3EVV:T*KB6GEM3;$\,W&Q]'UD
MLIQ[<W\YMM._I=WE_Y C.C]G<W+/7:U E4S;+">ULD9WAZPODNY3E\KIF1_)
MD<,^EN-&+):+QFV6.^>72[_E53)[>XVL+J^S%25]=A"2< _SCNH:*:RJDG(%
MVS4Z"*@&=%?JL3(?<S)T".Z*E3C&-NFA"LPB1N*8*\#:?IL!\&J]0SE8J4W/
M-S/Q^.;FKPHE*EM3\^="B1[<U/P5H41%:VK^7"C1@YN:D[1W4:(Z:FI.4I*:
M@Q+I6E/S%T21,H5^98KX\$T#GV- 6S-E@+ >ZQ^;.0./;@"R Z!-"E6&'0&2
M7 %0ADDSV&KZ=0I4ZRJE4MFG!62I]YJ:,@/:+/UNR%-_J57$6:G &]!*&DNV
M5LJ8^6OD'QD+I,]#8^2,7L_*UZ[YM]SP[UDR:VFEE)-Q0ZDULDG_CEBQ67KG
M+Y ?#GE++AN]0OJ^MET>75PE8[:(O*?9!\37D%'/(%\RZHEJY7(M9W%-C10K
MV*:DA*.4Z;5EBI3+E8D "<2A^50 7EL;7;(^6FK*5JF,3+D?\!X,*Z*/0HQD
MU02E!Q5:9I@X;O)AHYKF(\M[,_-7A1*5K:GY<Z%$#VYJ_HI0HJ(U-7\NE.C!
M3<U)VKLH41TU-2<I2<U!B72MJ?D+HDAY"&0# AUHQR(<ZC$@T-&IPT=BNRLT
M%:;Z"^XE#3B G<Y, AC \2!$!0@=@.UZ=UGZ>'BKI71GJ925X6L/?BW43"W<
M5B/9KZ^57STY1:Z^=ZC<]_QLF?WQ3BDE2Y;)6@L!&;]JLSPX\1WYU;B/Y*_O
M;)>AFVOE=4V$52,)#2G3_6K&":!?7-I\J%C%1YH*D;7@/,_S7J89X&-+/MHD
M+[ ]2:^K46!>4Z/EMP\C@U(2AL,_<IX(:%/"3P-M/6"Z$HOA)O7F(U)O;OZJ
M4**R-35_+I3HP4W-7Q%*5+2FYL^%$CVXJ3E)>Q<EJJ.FYB0EJ3DHD:XU-7]!
M% %0PF ^ "3X#TZ8)P#@+H088@ S@2.[[G= &L_A:X([_.RNJ^J8]D]!9U6%
MPM7J8!84)P#KZJ):>77A%ADS=Z5,7K!.%JXMDW( *RGJO<4*R!<5E<OLU=ME
MVNHB>6U'M7RH2:_3*P@+(<>&9QWUFOM>3]3RT6;P/-CS:3A<=]CW\Y!=I_*P
M<!J;9@0Y,(1@T(%?FX%%(-^PG.U^?PA%#B88#S)EKQ&2E*0D)2E)24I2DI+T
M9:<(H,_Y,R&>@T/[$[XSN'M/(.*N:SW176S@E1"*$'$$)@6HPH!6G-A%Y752
M5%(EU2#AZ+U\$%FJ%Q/<PJ2%19HL<ZO@P.8>[N=)T<<IQW:4=T\-7Q7\$DAA
MUWZ0JX!]OQ[9#_K'7R%\ZH(D)2E)24I2DI*4I"1]&2D2W7YIJ::F1D%VM6+4
M70@UB)VNC7$-'G+S/"=1;)*2E*0D)2E)24I2DCX?VJN!MOF$S<O;$$#FMX1^
MXN >?H,5;#><1I*2E*0D)2E)24I2DI+4]+1W VT%Q\[NG0Z?"U.B<PU18Z]+
M4I*2E*0D)2E)24I2DOY;VFN!M@-GV,(_:FH^Q0Z^P_Q9(-K3^ZSKDI2D)"4I
M24E*4I*2E*3_A?9JH.WDX+@QS+6?Q7Y=DI*4I"0E*4E)2E*2DM1<]*7^&-)!
M<SS ]G/Q'+X&3E*2DI2D)"4I24E*4I*:AT3^'SFQKYUFWESF     $E%3D2N
#0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139636372568288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  08,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOLIFE SOLUTIONS, INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3076866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3303 Monte Villa Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bothell<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">402-1400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">BioLife Solutions, Inc. Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BLFS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000834365<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>blfs-20230808_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="blfs-20230808.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000834365</identifier>
        </entity>
        <period>
            <startDate>2023-08-08</startDate>
            <endDate>2023-08-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0000834365</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-08-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">BIOLIFE SOLUTIONS, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-36362</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">94-3076866</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3303 Monte Villa Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Bothell</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">98021</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">425</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">402-1400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">BioLife Solutions, Inc. Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">BLFS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M& 6S, _ _5A*_=DPF];J/X?A?U!+ P04    " #R@0A7GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    " #R@0A7!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /*!"%<\55GE[P
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( /*!"%>97)PC$ 8  )PG   3              "  <T!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ \H$(5W[4J<Q*!   ?Q   !@
M             ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( /*!"%>?H!OPL0(  .(,   -              "  8X,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ \H$(5Y>*NQS     $P(   L
M     ( !:@\  %]R96QS+RYR96QS4$L! A0#%     @ \H$(5ZK$(A8S 0
M(@(   \              ( !4Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( /*!"%<D'INBK0   /@!   :              "  ;,1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /*!"%=ED'F2&0$  ,\#
M   3              "  9@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  .(3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="blfs-20230808.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biolifesolutions.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="blfs-20230808.htm">blfs-20230808.htm</File>
    <File>blfs-20230808.xsd</File>
    <File>blfs-20230808_lab.xml</File>
    <File>blfs-20230808_pre.xml</File>
    <File>blfsq22023earningsrelease.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "blfs-20230808.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "blfs-20230808.htm"
     ]
    },
    "labelLink": {
     "local": [
      "blfs-20230808_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "blfs-20230808_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "blfs-20230808.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "blfs",
   "nsuri": "http://www.biolifesolutions.com/20230808",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "blfs-20230808.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.biolifesolutions.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "blfs-20230808.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.biolifesolutions.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-23-028201-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-028201-xbrl.zip
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MZF7SJ4Q]=U3,?T)I9!-,H0;2I=/9 >@7"2 -!?T*(Y64)IRH64!J=@8LWYA
M5:*:7KB6/%9K!1.YN'KQA92;$&B#$4;N*8?G0&MQZ,JR-79=V=NNHF&!0P\S
MCZ>GO]YC&;&]AZ<9\;PZ&AN2SN@MIN2[=;-[_L9]'*42Z3 28-G@MG0'?X:&
M6M^</8+[7,:TRX\\=VU_W7<'U+7\F<&4<3&^)7J?$7RG8Q^\AH.#$9YPK?3:
M+Q@H$L_&9DQ8<5]<5Y A*AMF.>UK7_[[FO D$*JC\1(,3U9D!/.!SJ:6I1V!
MI9,#*SG?8OK3G\!D0K#IV+5X4^[X,D2+MR\/T"-)V '"*+_V@^:N X#AEZ5K
M#X9CU0P*VD$PV',<AF" 76F DQ GP+(%^\PR3DO>1CFKX?<!8!=(#+DR^=(6
M<P*.V4-?$G4Q$*4>XI])2)!MIE@;Z 1PBJ?]/HN80+SD)RRD?"#1E*'6@/:I
M0,VF84D'D$94"6.S6[BR%)#W*!5L\XKO\3"U MF05ZMTV'V&7>'P9 BR,CG<
M;HUI&J;UF,;,]$)U4,L:?;JI&9?Y5VC)IOJ:O?TI]BLBOTL>V(+MK+[T[N;W
MOM=9;QA69;4;LR_OG]U@9;*X#)!;J(O(6.-$[_6/4#?*A%/"749CZ1>^>2OQ
M-M6F%?'2-VW![;$G^?+4H;#O?S/FI/AY$!2D08.C3GKE+, )%[I9DNK3X<81
M1+/7KGTIR\B%8 A,(%/,8A5C((;JT'L6OAP@3[WK\:B$WPAY><3Y=BC*WUR"
M'V9&.^N7BJV2959^!']43'P[ FS0%233D!!!(@)R*F^YG6*!TTN_>V38)YZ7
MO9>5ABH5Z:I #ZGWMWK9"W/6N>FQ<Q4(V5Z^U26(S;[;JOO^XN3FTW5G]VL'
M\V\;2TN\7Q+*L@QPM0..@Z+:L(L36<I567F6C<,*?<BM@ DP$*7O">J3 0Y\
M66V6,)3%SB8,""-)",]X23!!.!&#B %=WJJ9Z"XE<[)GJ-)X];2K8C1KKW_C
MIUHVFLWRVTWFBOU&6B=YU&_6MIRHXN3LD2IA4:+VP),U=ZHM>;OVHEC Y&OW
M'/3P+7JOW0B\41+?39PW1E&)E] -BR;H,W4'$(\ P'6J'+M$ZC,&\(T3]3;J
M4;*]R'D-@?TVIGT76*C:'1W4'E#BSQTG7JJWI+#=2PE+Z7_%H/[_AM;_ 5!+
M P04    " #R@0A7-K?*"7("  "(!P  $0   &)L9G,M,C R,S X,#@N>'-D
MS57);MLP$+W[*UB=2RV6'4M"[ !-$*" NR!-T-P*BAK91"A2):G8^?M0M 1'
M69H*Z*&^F)IY;Y8W'.GT;%]Q= ]*,RF67N2''@)!9<'$9NG=7%_BQ#M;32:G
M'S"^_72U1A>2-A4(@\X5$ ,%VC&S168+Z*=4=^R>H.^<F%*J"N.5HYW+^D&Q
MS=:@:3B->UCO55DR2_,43BB.<Q+C64Y*G"[" M.4SN>+/(G+,OFXR6;A(LP7
MQ0R?0!KB64QC3*:S""?SA)P40-+I?.&"[G6FZ18J@FQK0F=[O?2VQM19$.QV
M.W\7^U)M@FD81L'ME_4/!_4Z+&?B;H#>YXKW^#AHW3G1T,-S7@Z#YTQR5H*6
MO#%64.U3605MVV$2)AXBQBB6-P8NK3X74)*&FZ77B-\-L30&A16?0ROO /#$
M;8C:@/E**M UH3 B^6J"4*L-JVJI#!*OANC$B=(T#?9MMQXZ:+F6E!AW1=X4
MQ^%Q>\31%,>1O]>%%_Q5VF$@)K0A@L*8W/8)][Q_4<-QTN-JZ'GC:W#!-%!_
M(^^# IB;W.OI]5OP]H#;PS G$4(:QV\MG:VNF2CEP6!-;>%97_T5E/WRO-B(
M5ZZ(^\N(HDKR=^Y34"M9@S(,]--M<@&V"LJEU^X4[F_M+TYRWU;20UXD&(Z@
M=0>6 GQ][*3GFH?:<K4= (>#-O]SX[6"L8U;BK:O#C?HD?VW_&OK1ZQ8>N?2
M?@\\U-INKCZ__XIQR0^D/FH?MX"2">9N7NA^$<+'3PA&CG4:/,<^B])H*+Z)
ME3L_;[(C=Y _$"GAM.'C><>RWJ1UQE[$;LF"X98=GI]LHC,<UGLU>0102P,$
M%     @ \H$(5^W)<PM*"@  &ET  !4   !B;&9S+3(P,C,P.# X7VQA8BYX
M;6S57%UOVS@6?>^OX&9?=H%A34J41!5M!MU,.R@VTP9-BAGL8F'P,Q%&E@)9
M:9)_OY1L)U(LV:)DJYJ'-HI]=7GNB<Z]O"3MMS\_+&+P767+*$W>G>#7Z 2H
M1*0R2J[?G7R[^@CIR<^GKUZ]_1N$?_SKZSGX)15W"Y7DX"Q3+%<2W$?Y#<AO
M%/@]S?Z,OC-P$;-<I]D"PM/RMK/T]C&+KF]RX"#'W9AMWLW>4!+R4/D"NIRY
MD'"F81@@"44H/"_@U-6:_G3]AJ  \4 2Z*L00>(*%S*'8$@]RGRI6.AX0>DT
MCI(_WQ3_<;94P(27+,M?WYW<Y/GMF]GL_O[^]0//XM=I=CUS$')G&^N3M?G#
MEOV]6UKC, QGY;M/ILNHR="XQ;,_?CN_%#=JP6"4+'.6B&* 9?1F6;YXG@J6
MEZSOQ05:+8K?X,8,%B]![$ 7OWY8RI/35P"LZ,C26'U5&A0_OWW]U#ID."LL
M9HFZ+OZV%RJ+4GF9LRP_9US%!GWI+7^\5>].EM'B-E:;UVXRI9O=QEE6\UJ@
M# N4V"]0_KUML-D ^ ?"FV]C/0"X,MS/A\*XB]//!X-[93*$.C[@RC"#(:\>
MJ ^)'.O9?1IJ,/3C(S[48Y'F+![AL7@>I@(Y+EXX-U?K80I'.Y)I.<XZ=5>@
MJH=<)5*MLF7--8CDNQ-S-9<JFE\J<9=%^>.'!W'#DFOUF2W4'''/=Y$,(:62
M0^(H!!GW-:18.J$6OJE>:)X_/=-SE<!OEYOARS%V#W!B$5G>HM!,+=.[3#S7
MMD7<5+!,K2JJ&YTE9MSE+5O?8% 6$X$5\-,-1K !"0J4;V?/\?0@,3XZ-?&D
M6$E%#4E<3 /2[&7HJ=@;^K.LE@9U&?=2B=?7Z?>9N756S+:*"UA<E&IJ=3C;
M^K.]SS8H62;V<+RVF(G4S'!N<UBC6V?IHELX>=KM+[ZBS0QZ M),JLS,6AL"
M:'SNL,.OHCQ6<Z&T&_J!@D0Q,YF4G,&0>PBZA'&!J<*8$5OA;IQ/3;0E*)!J
M@)U_\'^"#5Q[U3ZQUUVQ?3@YLEIMZ>@EUY=Q#Y+JD[/19?HRC":);MG8R_-W
MX\<4X;-TL;A+HE57M)Q[/G*(Z[A0"JDA\0B#7!B-2A<)' 84N;*S1AM'F)I0
MUR!!'65WG3;3N%^L@\DYLF(M>;$2[,[8>ZFVV>-HTMT94%6_NPWM15PL9\07
M-VFB/M\MN,KFE&A/"RP@5=0S^E444N8XD&.NM7(]S\B[JWY?.I^:=$M\H 0(
M5@B[RW:+N/V*'4+'D<5JP8254-M"[J71+6>CR;,MC*HR6VWL17F5L6(E]_)Q
MP=-X[C#N%JTI5"[&D&CM08J0!T,1<$:8JZGJW*[6/$]-CFMP8(6NNQ3K=.W7
M86\2CCW'[1:_E0 ;8^VEOKJGT:37&$!5=\T&]J+[D.1F7OPI$6EVFV9E8;W,
M6:[.TKLDSQ[/4JGF#&%?^-J%0O@,$HX#2%V70!DBPK43> AW+HX=QIN:0%>0
M00WS3Z!$;6@&:^2@@-Y=O5UXWZ_I [-Y9*4?@DBK-&!!3Z_DT,7_:"G#(MAJ
M(K&YK6]Z>2^E>8Z6I=\OV466?H],.'-MIM:^)!1ZCL,AP:YIFI%@4/- A+ZF
MR!1\N[S2/-!$$\H:;$4!&\"V::2%WZ[Y8SAKXR2.'H3U2!>[V1B0)UH<CYP@
M=H>WG1GVV-NGA(M,%7V\,EZ*LQF?ELL[E5T5VUK9%Y,0LCD1TI&N,C-_R<QT
M(R AY,7L@VKA"B%]*DG8-2WL&VQJJ<'@A:("&*P0@Q5D4&+NGAWV4KT_0QR2
MP"-GB4'<626*KJ3T2A9[G8^6,+J&64T:G>^Q3QR;TUQ/!QA^,2EI[GL.\4C
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M6=E]+G#70A7@89U;2V7MGPPJ.Y7KO\XLK8.R/[H,4"S[JYZZIDW6MTMG.,^
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MZ.FXU/!%L\,HF'#W<;R8>Z/AW>*9B!=XX.3@\8?NI7L\_N3@OU!+ P04
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M$?.2,(J!Q!X8Z3!X$3QJ-"%[8+=T1D9DF$9CPA'+>=^:H03R&*9 2^$ [!J
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MF.*%$!3I(\.)K":13"+^I/UG,X0*<]\:(KDWQ/&W(KJ>"HH&428 +< N*^\
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M**O05YX=A>0UFRFU@,0:DQ2&YHI>LZ<HH;DZ>4T8+& %30_KVJL3V&:LXO%
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M"I_EPV?#T$RGE.7 JND8WXSTO1_&J^GZ;)W[3WQ'1AV(3R]L4Y9#CJS1!Z@
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M/FO]23Y>W7QO'6",M8JC5G'4<W3H_M0&MG=7&UA%%Y<DNOBPB[SN-.YX%W5
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MB(+TRJE45>G7K2A=91B7$B\-4R&FC(@QBQ;;57C9TNED4[F2JDK]=N)H7:-
MBPIE(6\I<AY+U"NTE TMAJMXI71($:7I57\S596^-"?@RDS>"G)D?6V%FS+B
M1C%.B9&S:\:I= K4XJ)N2UHFJA+M/E6B/3)TS=:+^VJJ:+(BU1UT@K:+UWI0
ME*HH=>O[7[KF.L6=>D6JBE2WKO]M36\6+W)2]2KT+[VU;NQ4N([T]<7M,Q6D
M\[LE79.J'?WTGJH=K2:K:D>KVM&J=K2J';T)G:LJ *O:T8IRMDPY%3W4F/)
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MUH_?U<AMC\W,]A'G" CP4I_BG''L.^(!6G!7_.^T<X<;XK$8%P/Z^O!43&0
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M9G,M,C R,S X,#@N>'-D4$L! A0#%     @ \H$(5^W)<PM*"@  &ET  !4
M             ( !W!   &)L9G,M,C R,S X,#A?;&%B+GAM;%!+ 0(4 Q0
M   ( /*!"%=51[>TLP8  .XP   5              "  5D;  !B;&9S+3(P
M,C,P.# X7W!R92YX;6Q02P$"% ,4    " #R@0A7J6=AEP5)   Q0 4 '0
M            @ $_(@  8FQF<W$R,C R,V5A<FYI;F=S<F5L96%S92YH=&U0
52P4&      4 !0!/ 0  ?VL

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
